"","V1","V2","V3","V4"
"1","GSM225042","derived from H1-GFP labeled","H1 undifferentiated embryonic stem cells - GFP","H1 embryonic stem cells - GFP"
"2","GSM230294","derived from H9","H9 undifferentiated embryonic stem cells","H9 embryonic stem cells (leukocyte study)"
"3","GSM347922","H7 passage 73 Human Embryonic Stem Cells","Human Embryonic Stem Cells","H7 ESC"
"4","GSM347923","H9 passage 50 Human Embryonic Stem Cells","Human Embryonic Stem Cells","H9 ESC"
"5","GSM347924","H13B passage 43 Human Embryonic Stem Cells","Human Embryonic Stem Cells","H13B ESC"
"6","GSM347925","H14B passage 61 Human Embryonic Stem Cells","Human Embryonic Stem Cells","H14A ESC"
"7","GSM367062","Human ES cell line H9","Human embryonic stem cells","hES H9"
"8","GSM367061","Human ES cell line BG01","Human embryonic stem cells","hES BG01"
"9","GSM378811","cell type: H1 passage 42 Human Embryonic Stem Cells","Human Embryonic Stem Cells","H1L ESC (set of 16)"
"10","GSM530602","c(\"cell type: Human embryonic stem cells (hESC)\", \"cell subtype: BGO1 hESC\")","BGO1 hESC","BGO1 hESC"
"11","GSM530605","c(\"cell type: Human embryonic stem cells (hESC)\", \"cell subtype: BGO1-Nanog transgenic hESC line\")","BGO1-Nanog transgenic hESC line","BGO1-Nanog transgenic hESC line"
"12","GSM530607","c(\"cell type: Human embryonic stem cells (hESC)\", \"cell subtype: BGO1 hESC (mTESR)\")","BGO1 hESC (mTESR)","BGO1 hESC (mTESR)"
"13","GSM530601","c(\"cell type: Human embryonic stem cells (hESC)\", \"cell subtype: WIBR3 hESC (5%pO2)\")","WIBR3 hESC (5%pO2)","WIBR3 hESC (5%pO2)"
"14","GSM530603","c(\"cell type: Human embryonic stem cells (hESC)\", \"cell subtype: WIBR2 hESC\")","WIBR2 hESC","WIBR2 hESC"
"15","GSM530604","c(\"cell type: Human embryonic stem cells (hESC)\", \"cell subtype: WIBR3\")","WIBR3","WIBR3"
"16","GSM530611","c(\"cell type: Human embryonic stem cells (hESC)\", \"cell subtype: WIBR3 hESC\")","WIBR3 hESC","WIBR3 hESC"
"17","GSM530606","c(\"cell type: Human embryonic stem cells (hESC)\", \"cell subtype: WIBR1 hESC\")","WIBR1 hESC","WIBR1 hESC"
"18","GSM469409","c(\"cell line: Day-17 neuroepithelia from hESC\", \"genotype: Line H9\")","Day-17 neuroepithelia from hESC","Day-17 neuroepithelial cells"
"19","GSM469411","c(\"cell line: Day-210 RA-specified astrocytes\", \"genotype: Line H9\")","Day-210 RA-specified astrocytes","Day-210 RA-specificed astrocytes"
"20","GSM469412","c(\"cell line: Day-210 FGF8-specified astrocytes\", \"genotype: Line H9\")","Day-210 FGF8-specified astrocytes","Day-210 FGF8-specified astrocytes"
"21","GSM172865","c(\"Differentiation of hES cells line VUB01 towards neural rosettes\", \"Neural precursor phenotype\")","Neural precursor cells derived from hES cells line VUB01, biological replicate  1","NPC_VUB01_1"
"22","GSM172866","c(\"Differentiation of hES cells line VUB01 towards neural rosettes\", \"Neural precursor phenotype\")","Neural precursor cells derived from hES cells line VUB01, biological replicate  2","NPC_VUB01_2"
"23","GSM172867","c(\"Differentiation of hES cells line VUB01 towards neural rosettes\", \"Neural precursor phenotype\")","Neural precursor cells derived from hES cells line VUB01, biological replicate  3","NPC_VUB01_3"
"24","GSM172868","c(\"Differentiation of hES cells line SA01 towards neural rosettes\", \"Neural precursor phenotype\")","Neural precursor cells derived from hES cells line SA01, biological replicate  1","NPC_SA01_1"
"25","GSM172869","c(\"Differentiation of hES cells line SA01 towards neural rosettes\", \"Neural precursor phenotype\")","Neural precursor cells derived from hES cells line SA01, biological replicate  2","NPC_SA01_2"
"26","GSM172870","c(\"Differentiation of hES cells line SA01 towards neural rosettes\", \"Neural precursor phenotype\")","Neural precursor cells derived from hES cells line SA01, biological replicate  3","NPC_SA01_3"
"27","GSM347919","Human Fibroblast cells","Human Fibroblast cells","SMA 3813"
"28","GSM347920","Human Fibroblast cells","Human Fibroblast cells","SMA 3814"
"29","GSM347916","Human iPS cells","Human iPS cells","iPS SMA 3.5"
"30","GSM347917","Human iPS cells","Human iPS cells","iPS SMA 3.6"
"31","GSM347918","Human iPS cells","Human iPS cells","iPS SMA 4.2"
"32","GSM366942","Human fibroblasts","PDB fibroblasts","PDB fibroblasts"
"33","GSM367219","parental cell line: AG20442","Factor-free human induced pluripotent stem cells (hIPSC)","iPS PDB 1lox-17Puro-5"
"34","GSM367240","parental cell line: AG20442","Factor-free human induced pluripotent stem cells (hIPSC)","iPS PDB 1lox-17Puro-10"
"35","GSM367241","parental cell line: AG20442","Factor-free human induced pluripotent stem cells (hIPSC)","iPS PDB 1lox-21Puro-20"
"36","GSM367242","parental cell line: AG20442","Factor-free human induced pluripotent stem cells (hIPSC)","iPS PDB 1lox-21Puro-26"
"37","GSM367243","parental cell line: AG20442","Virus-carrying human induced pluripotent stem cells (hIPSC)","iPS PDB 2lox-5"
"38","GSM367244","parental cell line: AG20442","Virus-carrying human induced pluripotent stem cells (hIPSC)","iPS PDB 2lox-22"
"39","GSM367245","parental cell line: AG20442","Virus-carrying human induced pluripotent stem cells (hIPSC)","iPS PDB 2lox-21"
"40","GSM367258","parental cell line: AG20442","Virus-carrying human induced pluripotent stem cells (hIPSC)","iPS PDB 2lox-17"
"41","GSM372142","c(\"cell line: ATCC CRL2097\", \"cell type: human foreskin fibroblasts\")","ATCC cell line CRL2097 (human foreskin fibroblast)","fibroblasts_1"
"42","GSM372144","c(\"cell line: ATCC CRL2097\", \"cell type: human foreskin fibroblasts\")","ATCC cell line CRL2097 (human foreskin fibroblast)","fibroblasts_2"
"43","GSM372146","c(\"cell line: ATCC CRL2097\", \"cell type: human foreskin fibroblasts\")","ATCC cell line CRL2097 (human foreskin fibroblast)","fibroblasts_3"
"44","GSM372157","c(\"cell line: ATCC CRL2097\", \"cell type: induced pluripotent stem cells derived from human foreskin fibroblasts\")","induced pluripotent stem cells derived from ATCC cell line CRL2097 (human foreskin fibroblasts)","iPS_undifferentiated_1"
"45","GSM372158","c(\"cell line: ATCC CRL2097\", \"cell type: induced pluripotent stem cells derived from human foreskin fibroblasts\")","induced pluripotent stem cells derived from ATCC cell line CRL2097 (human foreskin fibroblasts)","iPS_undifferentiated_2"
"46","GSM372159","c(\"cell line: ATCC CRL2097\", \"cell type: induced pluripotent stem cells derived from human foreskin fibroblasts\")","induced pluripotent stem cells derived from ATCC cell line CRL2097 (human foreskin fibroblasts)","iPS_undifferentiated_3"
"47","GSM372154","c(\"cell line: ATCC CRL2097\", \"cell type: human foreskin fibroblasts subjected to a hepatic differentiation protocol. samples harvested on d20 of protocol\")","induced pluripotent stem cells derived from ATCC cell line CRL2097 (human foreskin fibroblasts)","iPS_d20_hepatic differentiated_1"
"48","GSM372155","c(\"cell line: ATCC CRL2097\", \"cell type: human foreskin fibroblasts subjected to a hepatic differentiation protocol. samples harvested on d20 of protocol\")","induced pluripotent stem cells derived from ATCC cell line CRL2097 (human foreskin fibroblasts)","iPS_d20_hepatic differentiated_2"
"49","GSM372156","c(\"cell line: ATCC CRL2097\", \"cell type: human foreskin fibroblasts subjected to a hepatic differentiation protocol. samples harvested on d20 of protocol\")","induced pluripotent stem cells derived from ATCC cell line CRL2097 (human foreskin fibroblasts)","iPS_d20_hepatic differentiated_3"
"50","GSM402707","cell type: fibroblast","Human newborn fibroblast","Human newborn fibroblast"
"51","GSM402717","c(\"cell line: hiPS induced pluripotent embryonic stem cell line (Line 1)\", \"protocol: direct delivery of reprogramming proteins\")","human newborn fibroblasts","Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins (Line 1)"
"52","GSM402752","c(\"cell line: hiPS induced pluripotent embryonic stem cell line (Line 2)\", \"protocol: direct delivery of reprogramming proteins\")","Human newborn fibroblasts","Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins (Line 2)"
"53","GSM402806","c(\"cell line: hiPS induced pluripotent embryonic stem cell line\", \"protocol: retroviral transfection of reprogramming genes\")","human newborn fibroblasts","Human Induced Pluripotent Stem Cells by retroviral transfection of Reprogramming genes"
"54","GSM500995","c(\"cell type: Foreskin Cells Parental\", \"developmental stage: adult\")","Foreskin Cells Parental","Foreskin_GSM378832"
"55","GSM500996","c(\"cell type: iPS cells from episomal vectors (Defined Factor)\", \"developmental stage: undifferentiated\")","iPS cells from episomal vectors (Defined Factor)","JT-iPSC_GSM378833"
"56","GSM500997","c(\"cell type: iPS cells from episomal vectors (Defined Factor sub-clone)\", \"developmental stage: undifferentiated\")","iPS cells from episomal vectors (Defined Factor sub-clone)","JT-iPSC_GSM378834"
"57","GSM500998","c(\"cell type: iPS cells from episomal vectors (Defined Factor sub-clone)\", \"developmental stage: undifferentiated\")","iPS cells from episomal vectors (Defined Factor sub-clone)","JT-iPSC_GSM378836"
"58","GSM500999","c(\"cell type: iPS cells from episomal vectors (Defined Factor sub-clone)\", \"developmental stage: undifferentiated\")","iPS cells from episomal vectors (Defined Factor sub-clone)","JT-iPSC_GSM378837"
"59","GSM501000","c(\"cell type: iPS cells from episomal vectors (Defined Factor)\", \"developmental stage: undifferentiated\")","iPS cells from episomal vectors (Defined Factor)","JT-iPSC_GSM378838"
"60","GSM501001","c(\"cell type: adipose stem cells derived from adult human donor\", \"developmental stage: undifferentiated\")","adipose stem cells derived from adult human donor","human adipose stem cell replicate 1"
"61","GSM501002","c(\"cell type: adipose stem cells derived from adult human donor\", \"developmental stage: adult\")","adipose stem cells derived from adult human donor","human adipose stem cell replicate 2"
"62","GSM501003","c(\"cell type: adipose stem cells derived from adult human donor\", \"developmental stage: adult\")","adipose stem cells derived from adult human donor","human adipose stem cell replicate 3"
"63","GSM501004","c(\"cell type: iPSC derived from hASC using lentiviral reprogramming vector\", \"developmental stage: undifferentiated\")","iPSC derived from hASC using lentiviral reprogramming vector","hASC-derived iPS cells using lentiviral factors replicate 1"
"64","GSM501005","c(\"cell type: iPSC derived from hASC using lentiviral reprogramming vector\", \"developmental stage: undifferentiated\")","iPSC derived from hASC using lentiviral reprogramming vector","hASC-derived iPS cells using lentiviral factors replicate 2"
"65","GSM501006","c(\"cell type: iPSC derived from hASC using lentiviral reprogramming vector\", \"developmental stage: undifferentiated\")","iPSC derived from hASC using lentiviral reprogramming vector","hASC-derived iPS cells using lentiviral factors replicate 3"
"66","GSM501007","c(\"cell type: iPSC derived from hASC using minicircle reprogramming vector\", \"developmental stage: undifferentiated\")","iPSC derived from hASC using minicircle reprogramming vector","minicircle-derived iPSC subclone 1"
"67","GSM501008","c(\"cell type: iPSC derived from hASC using minicircle reprogramming vector\", \"developmental stage: undifferentiated\")","iPSC derived from hASC using minicircle reprogramming vector","minicircle-derived iPSC subclone 2"
"68","GSM501009","c(\"cell type: iPSC derived from hASC using minicircle reprogramming vector\", \"developmental stage: undifferentiated\")","iPSC derived from hASC using minicircle reprogramming vector","minicircle-derived iPSC subclone 3"
"69","GSM239260","c(\"Human iliac mesenchymal stem cells (MSC) were purchased from BioWhittaker Inc (Walkersville, MD) or obtained from iliac crest according to protocol approved by ethical authorities at Hiroshima University. Culture of MSC and their differentiation from the adipocyte lineage were performed as described.\", \"(Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, et al. (2005) \", \"Alveolar bone marrow as a cell source for regenerative medicine: \", \"differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 20: 399-409.)\"
)","MSC_adipogenesis","adipocyte_rep1"
"70","GSM239379","Human iliac mesenchymal stem cells (MSC) were purchased from BioWhittaker Inc (Walkersville, MD) or obtained from iliac crest according to protocol approved by ethical authorities at Hiroshima University. Culture of MSC and their differentiation from the adipocyte lineage were performed as described. (Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, et al. (2005) Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 20: 399-409.)","MSC_adipogenesis","adipocyte_rep2"
"71","GSM239457","Human iliac mesenchymal stem cells (MSC) were purchased from BioWhittaker Inc (Walkersville, MD) or obtained from iliac crest according to protocol approved by ethical authorities at Hiroshima University. Culture of MSC and their differentiation from the adipocyte lineage were performed as described. (Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, et al. (2005) Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 20: 399-409.)","MSC_adipogenesis","adipocyte_rep3"
"72","GSM322374","Gender: female","Human  lipoma-derived mesenchymal stem cells","LM6, biological rep1"
"73","GSM322375","Gender: female","Human  lipoma-derived mesenchymal stem cells","LM6, biological rep2"
"74","GSM322376","Gender: female","Human  adipose-derived mesenchymal stem cells","AM3, biological rep1"
"75","GSM322377","Gender: female","Human  adipose-derived mesenchymal stem cells","AM3, biological rep2"
"76","GSM250019","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: male\", \"age: 67 years\", \"treatment: none\")","bone marrow MSC in culture from normal donor 1","BM-MSC culture rep 1"
"77","GSM250020","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: male\", \"age: 72 years\", \"treatment: none\")","bone marrow MSC in culture from normal donor 2","BM-MSC culture rep 2"
"78","GSM250021","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: female\", \"age: 74 years\", \"treatment: none\")","bone marrow MSC in culture from normal donor 3","BM-MSC culture rep 3"
"79","GSM451153","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: male\", \"age: 67 years\", \"treatment: dexamethasone\", \"treatment time: 1 day\")","bone marrow MSC in culture, stimulated for osteogenic induction for 1 day from normal donor 1","BM-MSC culture osteogenic induction for 1 day rep 1"
"80","GSM451154","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: male\", \"age: 72 years\", \"treatment: dexamethasone\", \"treatment time: 1 day\")","bone marrow MSC in culture, stimulated for osteogenic induction for 1 day from normal donor 2","BM-MSC culture osteogenic induction for 1 day rep 2"
"81","GSM451155","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: female\", \"age: 74 years\", \"treatment: dexamethasone\", \"treatment time: 1 day\")","bone marrow MSC in culture, stimulated for osteogenic induction for 1 day from normal donor 3","BM-MSC culture osteogenic induction for 1 day rep 3"
"82","GSM451156","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: male\", \"age: 67 years\", \"treatment: dexamethasone\", \"treatment time: 3 days\")","bone marrow MSC in culture, stimulated for osteogenic induction for 3 days from normal donor 1","BM-MSC culture osteogenic induction for 3 days rep 1"
"83","GSM451157","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: male\", \"age: 72 years\", \"treatment: dexamethasone\", \"treatment time: 3 days\")","bone marrow MSC in culture, stimulated for osteogenic induction for 3 days from normal donor 2","BM-MSC culture osteogenic induction for 3 days rep 2"
"84","GSM451158","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: female\", \"age: 74 years\", \"treatment: dexamethasone\", \"treatment time: 3 days\")","bone marrow MSC in culture, stimulated for osteogenic induction for 3 days from normal donor 3","BM-MSC culture osteogenic induction for 3 days rep 3"
"85","GSM451160","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: male\", \"age: 72 years\", \"treatment: dexamethasone\", \"treatment time: 7 days\")","bone marrow MSC in culture, stimulated for osteogenic induction for 7 days from normal donor 2","BM-MSC culture osteogenic induction for 7 days rep 2"
"86","GSM451161","c(\"cell type: bone marrow-derived mesenchymal stem cells\", \"gender: female\", \"age: 74 years\", \"treatment: dexamethasone\", \"treatment time: 7 days\")","bone marrow MSC in culture, stimulated for osteogenic induction for 7 days from normal donor 3","BM-MSC culture osteogenic induction for 7 days rep 3"
"87","GSM260657","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3","donor 1, unstimulated","human BM MSC unstimulated rep 1"
"88","GSM260658","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3","donor 2, unstimulated","human BM MSC unstimulated rep 2"
"89","GSM260659","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3","donor 3, unstimulated","human BM MSC unstimulated rep 3"
"90","GSM260661","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3","donor 5, unstimulated","human BM MSC unstimulated rep 5"
"91","GSM260662","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3","donor 6, unstimulated","human BM MSC unstimulated rep 6"
"92","GSM260663","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 1 day","donor 1, stimulated with BMP2 for 1 day","human BM MSC BMP2 stimulated day 1 rep 1"
"93","GSM260664","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 1 day","donor 2, stimulated with BMP2 for 1 day","human BM MSC BMP2 stimulated day 1 rep 2"
"94","GSM260665","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 1 day","donor 3, stimulated with BMP2 for 1 day","human BM MSC BMP2 stimulated day 1 rep 3"
"95","GSM260666","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 3 days","donor 1, stimulated with BMP2 for 3 days","human BM MSC BMP2 stimulated day 3 rep 1"
"96","GSM260667","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 3 days","donor 2, stimulated with BMP2 for 3 days","human BM MSC BMP2 stimulated day 3 rep 2"
"97","GSM260668","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 3 days","donor 3, stimulated with BMP2 for 3 days","human BM MSC BMP2 stimulated day 3 rep 3"
"98","GSM260669","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 7 days","donor 1, stimulated with BMP2 for 7 days","human BM MSC BMP2 stimulated day 7 rep 1"
"99","GSM260670","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 7 days","donor 2, stimulated with BMP2 for 7 days","human BM MSC BMP2 stimulated day 7 rep 2"
"100","GSM260671","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 7 days","donor 3, stimulated with BMP2 for 7 days","human BM MSC BMP2 stimulated day 7 rep 3"
"101","GSM260672","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 21 days","donor 1, stimulated with BMP2 for 21 days","human BM MSC BMP2 stimulated day 21 rep 1"
"102","GSM260673","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 21 days","donor 2, stimulated with BMP2 for 21 days","human BM MSC BMP2 stimulated day 21 rep 2"
"103","GSM260674","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant BMP-2 for 21 days","donor 3, stimulated with BMP2 for 21 days","human BM MSC BMP2 stimulated day 21 rep 3"
"104","GSM260675","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 1 day","donor 4, stimulated with TGFb3 for 1 day","human BM MSC TGFb3 stimulated day 1 rep 1"
"105","GSM260676","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 1 day","donor 5, stimulated with TGFb3 for 1 day","human BM MSC TGFb3 stimulated day 1 rep 2"
"106","GSM260678","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 3 days","donor 4, stimulated with TGFb3 for 3 days","human BM MSC TGFb3 stimulated day 3 rep 1"
"107","GSM260679","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 3 days","donor 5, stimulated with TGFb3 for 3 days","human BM MSC TGFb3 stimulated day 3 rep 2"
"108","GSM260680","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 3 days","donor 6, stimulated with TGFb3 for 3 days","human BM MSC TGFb3 stimulated day 3 rep 3"
"109","GSM260681","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 7 days","donor 4, stimulated with TGFb3 for 7 days","human BM MSC TGFb3 stimulated day 7 rep 1"
"110","GSM260682","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 7 days","donor 5, stimulated with TGFb3 for 7 days","human BM MSC TGFb3 stimulated day 7 rep 2"
"111","GSM260683","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 7 days","donor 6, stimulated with TGFb3 for 7 days","human BM MSC TGFb3 stimulated day 7 rep 3"
"112","GSM260684","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 21 days","donor 4, stimulated with TGFb3 for 21 days","human BM MSC TGFb3 stimulated day 21 rep 1"
"113","GSM260685","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 21 days","donor 5, stimulated with TGFb3 for 21 days","human BM MSC TGFb3 stimulated day 21 rep 2"
"114","GSM260686","human BM-MSC cultured in Éø-MEM, supplemented with 10% fetal bovine serum (FBS), 1ng/ml basic fibroblast growth factor, 100U/ml penicillin and 100É g/ml streptomycin at passage 3; thereafter cells were pelleted and cultured in 500 É l DMEM supplemented with 0.1 É M dexamethasone, 0.17 mM ascorbate-2 phosphate, 1% insulin-transferrin-sodium selenite supplement and 100ng/ml of recombinant TGFb3 for 21 days","donor 6, stimulated with TGFb3 for 21 days","human BM MSC TGFb3 stimulated day 21 rep 3"
"115","GSM540714","c(\"cell line: Human Embryonic Stem Cells (hESC H9)\", \"cell population: CD326negCD56+ cells\")","Human Embryonic Stem Cells (hESC H9)","Mesodermal progenitor population, 1"
"116","GSM540715","c(\"cell line: Human Embryonic Stem Cells (hESC H9)\", \"cell population: CD326negCD56+ cells\")","Human Embryonic Stem Cells (hESC H9)","Mesodermal progenitor population, 2"
"117","GSM540716","c(\"cell line: Human Embryonic Stem Cells (hESC H9)\", \"cell population: CD326negCD56+ cells\")","Human Embryonic Stem Cells (hESC H9)","Mesodermal progenitor population, 3"
"118","GSM265494","DP2-P4, human dental pulp stem cells (hDPSCs) (14 year-old)","dental pulp cells (DP2) at passage 4","dental pulp cells (DP2) at passage 4"
"119","GSM265495","DP2-P10, human dental pulp stem cells (hDPSCs) (14 year-old)","dental pulp cells (DP2) at passage 10","dental pulp cells (DP2) at passage 10"
"120","GSM265496","DP28-P4, human dental pulp stem cells (hDPSCs) (14 year-old)","dental pulp cells (DP28) at passage 4","dental pulp cells (DP28) at passage 4"
"121","GSM265497","DP28-P10, human dental pulp stem cells (hDPSCs) (14 year-old)","dental pulp cells (DP28) at passage 10","dental pulp cells (DP28) at passage 10"
"122","GSM265498","DP31-P4, human dental pulp stem cells (hDPSCs) (14 year-old)","dental pulp cells (DP31) at passage 4","dental pulp cells (DP31) at passage 4"
"123","GSM265499","DP31-P10, human dental pulp stem cells (hDPSCs) (14 year-old)","dental pulp cells (DP31) at passage 10","dental pulp cells (DP31) at passage 10"
"124","GSM299095","c(\"Female, age 47\", \"Disease status: HB (control (stress incontinence, no bladder pain))\", \"Culture medium: DM (differentiating medium)\")","human","human cultured bladder HB DM, subject 8"
"125","GSM299096","c(\"Female, age 57\", \"Disease status: HB (control (stress incontinence, no bladder pain))\", \"Culture medium: DM (differentiating medium)\")","human","human cultured bladder HB DM, subject 12"
"126","GSM299097","c(\"Female, age 56\", \"Disease status: HB (control (stress incontinence, no bladder pain))\", \"Culture medium: DM (differentiating medium)\")","human","human cultured bladder HB DM, subject 13"
"127","GSM299098","c(\"Female, age 47\", \"Disease status: HB (control (stress incontinence, no bladder pain))\", \"Culture medium: KM (proliferating medium)\")","human","human cultured bladder HB KM, subject 8"
"128","GSM299099","c(\"Female, age 57\", \"Disease status: HB (control (stress incontinence, no bladder pain))\", \"Culture medium: KM (proliferating medium)\")","human","human cultured bladder HB KM, subject 12"
"129","GSM299100","c(\"Female, age 56\", \"Disease status: HB (control (stress incontinence, no bladder pain))\", \"Culture medium: KM (proliferating medium)\")","human","human cultured bladder HB KM, subject 13"
"130","GSM119354","Cells were harvested at day 0, the first day of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 0, donor 1"
"131","GSM119357","Cells were harvested at day 8 of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 8, donor 1"
"132","GSM119359","Cells were harvested at day 14 of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 14, donor 1"
"133","GSM119360","Cells were harvested at day 21 of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 21, donor 1"
"134","GSM119361","Cells were harvested at day 28 of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 28, donor 1"
"135","GSM119362","Cells were harvested at day 0, the first day of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 0, donor 2"
"136","GSM119366","Cells were harvested at day 8 of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 8, donor 2"
"137","GSM119369","Cells were harvested at day 14 of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 14, donor 2"
"138","GSM119371","Cells were harvested at day 21 of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 21, donor 2"
"139","GSM119372","Cells were harvested at day 28 of air-liquid interface culture","Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy","Bronchial epithelial cells, day 28, donor 2"
"140","GSM346943","Human foreskin fibroblasts (HFF) BJ","Fibroblast control (transwell bottom)","Fibroblasts uninfected control, biological rep 1"
"141","GSM346944","Human foreskin fibroblasts (HFF) BJ","Fibroblast control (transwell bottom)","Fibroblasts uninfected control, biological rep 2"
"142","GSM346941","Human foreskin fibroblasts (HFF) BJ","Fibroblasts infected with T. cruzi (transwell bottom)","Fibroblasts infected with T. cruzi, biological rep 1"
"143","GSM346942","Human foreskin fibroblasts (HFF) BJ","Fibroblasts infected with T. cruzi (transwell bottom)","Fibroblasts infected with T. cruzi, biological rep 2"
"144","GSM501890","c(\"tissue: normal breast\", \"cell type: normal fibroblast\")","Fibroblast isolated from adjacent normal breast tissue","normal fibroblast_case1"
"145","GSM501891","c(\"tissue: normal breast\", \"cell type: normal fibroblast\")","Fibroblast isolated from adjacent normal breast tissue","normal fibroblast_case2"
"146","GSM501892","c(\"tissue: normal breast\", \"cell type: normal fibroblast\")","Fibroblast isolated from adjacent normal breast tissue","normal fibroblast_case5"
"147","GSM501893","c(\"tissue: normal breast\", \"cell type: normal fibroblast\")","Fibroblast isolated from adjacent normal breast tissue","normal fibroblast_case6"
"148","GSM501894","c(\"tissue: normal breast\", \"cell type: normal fibroblast\")","Fibroblast isolated from adjacent normal breast tissue","normal fibroblast_case7"
"149","GSM501895","c(\"tissue: normal breast\", \"cell type: normal fibroblast\")","Fibroblast isolated from adjacent normal breast tissue","normal fibroblast_case8"
"150","GSM305784","tissue: primary human umbilical vein endothelial cells (HUVECs)","HUVEC control monolayer","HUVECs Non intoxicated Rep1"
"151","GSM305785","tissue: primary human umbilical vein endothelial cells (HUVECs)","HUVEC control monolayer","HUVECs Non intoxicated Rep2"
"152","GSM305786","tissue: primary human umbilical vein endothelial cells (HUVECs)","LT-intoxicated HUVEC monolayer, 4h","HUVECs Intoxicated by LT _4h"
"153","GSM305787","tissue: primary human umbilical vein endothelial cells (HUVECs)","LT-intoxicated HUVEC monolayer, 8h","HUVECs Intoxicated by LT 8h"
"154","GSM330313","c(\"untreated\", \"HUVEC monolayer\")","HUVEC control","HUVEC control_V1"
"155","GSM335393","c(\"untreated\", \"HUVEC monolayer\")","HUVEC control","HUVEC control_V2"
"156","GSM335851","c(\"untreated\", \"HUVEC monolayer\")","HUVEC control","HUVEC control_V3"
"157","GSM330314","c(\"FPV-infected\", \"HUVEC monolayer\")","FPV-infected HUVEC","FPV-infected HUVEC_V1"
"158","GSM335395","c(\"FPV-infected\", \"HUVEC monolayer\")","FPV-infected HUVEC","FPV-infected HUVEC_V2"
"159","GSM335859","c(\"FPV-infected\", \"HUVEC monolayer\")","FPV-infected HUVEC","FPV-infected HUVEC_V3"
"160","GSM330315","c(\"PR8-infected\", \"HUVEC monolayer\")","PR8-infected HUVEC","PR8-infected HUVEC_V1"
"161","GSM335396","c(\"PR8-infected\", \"HUVEC monolayer\")","PR8-infected HUVEC","PR8-infected HUVEC_V2"
"162","GSM335904","c(\"PR8-infected\", \"HUVEC monolayer\")","PR8-infected HUVEC","PR8-infected HUVEC_V3"
"163","GSM330316","c(\"H5N1-infected\", \"HUVEC monolayer\")","H5N1-infected HUVEC","H5N1-infected HUVEC_V1"
"164","GSM335906","c(\"H5N1-infected\", \"HUVEC monolayer\")","H5N1-infected HUVEC","H5N1-infected HUVEC_V2"
"165","GSM336559","c(\"H5N1-infected\", \"HUVEC monolayer\")","H5N1-infected HUVEC","H5N1-infected HUVEC_V3"
"166","GSM346951","Human microvascular endothelial cells (HMVEC)","Endothelial cells control (transwell bottom)","Endothelial cells uninfected control, biological rep 1"
"167","GSM346952","Human microvascular endothelial cells (HMVEC)","Endothelial cells control (transwell bottom)","Endothelial cells uninfected control, biological rep 2"
"168","GSM385333","c(\"cell type: Human umbilical vein endothelial cells\", \"treatment: uninduced\")","HUVEC, starved, uninduced","HUVEC_uninduced"
"169","GSM385338","c(\"cell type: Human umbilical vein endothelial cells\", \"treatment: VEGF\", \"time: 30 min\")","HUVEC, starved, 30min VEGF induced","HUVEC_VEGF_30min"
"170","GSM385350","c(\"cell type: Human umbilical vein endothelial cells\", \"treatment: VEGF\", \"time: 60 min\")","HUVEC, starved, 60min VEGF induced","HUVEC_VEGF_60min"
"171","GSM385353","c(\"cell type: Human umbilical vein endothelial cells\", \"treatment: VEGF\", \"time: 150 min\")","HUVEC, starved, 150min VEGF induced","HUVEC_VEGF_150min"
"172","GSM410666","c(\"cell type: lymphatic endothelial cell\", \"infection: none\")","lymphatic endothelial cells","LEC control, rep1"
"173","GSM410667","c(\"cell type: lymphatic endothelial cell\", \"infection: none\")","lymphatic endothelial cells","LEC control, rep2"
"174","GSM410668","c(\"cell type: lymphatic endothelial cell\", \"infection: none\")","lymphatic endothelial cells","LEC control, rep3"
"175","GSM410669","c(\"cell type: lymphatic endothelial cell\", \"infection: none\")","lymphatic endothelial cells","LEC control, rep4"
"176","GSM410672","c(\"cell type: lymphatic endothelial cell\", \"infection: KSHV\")","lymphatic endothelial cells, KSHV-infected, 72h","LEC KSHV 72h, rep1"
"177","GSM410673","c(\"cell type: lymphatic endothelial cell\", \"infection: KSHV\")","lymphatic endothelial cells, KSHV-infected, 72h","LEC KSHV 72h, rep2"
"178","GSM410674","c(\"cell type: lymphatic endothelial cell\", \"infection: KSHV\")","lymphatic endothelial cells, KSHV-infected, 72h","LEC KSHV 72h, rep3"
"179","GSM410675","c(\"cell type: lymphatic endothelial cell\", \"infection: KSHV\")","lymphatic endothelial cells, KSHV-infected, 72h","LEC KSHV 72h, rep4"
"180","GSM410678","c(\"cell type: blood vessel endothelial cell\", \"infection: none\")","blood vessel endothelial cells","BEC control, rep1"
"181","GSM410679","c(\"cell type: blood vessel endothelial cell\", \"infection: none\")","blood vessel endothelial cells","BEC control, rep2"
"182","GSM410680","c(\"cell type: blood vessel endothelial cell\", \"infection: none\")","blood vessel endothelial cells","BEC control, rep3"
"183","GSM410681","c(\"cell type: blood vessel endothelial cell\", \"infection: none\")","blood vessel endothelial cells","BEC control, rep4"
"184","GSM410684","c(\"cell type: blood vessel endothelial cell\", \"infection: KSHV\")","blood vessel endothelial cells, KSHV-infected, 72h","BEC KSHV 72h, rep1"
"185","GSM410685","c(\"cell type: blood vessel endothelial cell\", \"infection: KSHV\")","blood vessel endothelial cells, KSHV-infected, 72h","BEC KSHV 72h, rep2"
"186","GSM410686","c(\"cell type: blood vessel endothelial cell\", \"infection: KSHV\")","blood vessel endothelial cells, KSHV-infected, 72h","BEC KSHV 72h, rep3"
"187","GSM410687","c(\"cell type: blood vessel endothelial cell\", \"infection: KSHV\")","blood vessel endothelial cells, KSHV-infected, 72h","BEC KSHV 72h, rep4"
"188","GSM476782","c(\"cell type: Endothelial cells\", \"treatment: none\", \"time point: 0h\")","Human umbilical cord","Endothelial cells; control; 0h"
"189","GSM476785","c(\"cell type: Endothelial cells\", \"treatment: none\", \"time point: 16h\")","Human umbilical cord","Endothelial cells; control; 16h"
"190","GSM476783","c(\"cell type: Endothelial cells\", \"treatment: IL-1beta\", \"time point: 4h\")","Human umbilical cord","Endothelial cells; IL-1beta; 4h"
"191","GSM476784","c(\"cell type: Endothelial cells\", \"treatment: IL-1beta\", \"time point: 8h\")","Human umbilical cord","Endothelial cells; IL-1beta; 8h"
"192","GSM476786","c(\"cell type: Endothelial cells\", \"treatment: IL-1beta\", \"time point: 16h\")","Human umbilical cord","Endothelial cells; IL-1beta; 16h"
"193","GSM492832","c(\"developmental stage: mature\", \"cell type: Umbilical Vein Endothelial Cells\")","Human Umbilical Vein ECs cultured in serum free conditions for 48 hours","Human Umbilical Vein ECs_1"
"194","GSM492833","c(\"developmental stage: mature\", \"cell type: Umbilical Vein Endothelial Cells\")","Human Umbilical Vein ECs cultured in serum free conditions for 48 hours","Human Umbilical Vein ECs_2"
"195","GSM551183","tissue: Human umbilical vein endothelial cell","Unstimulated HUVEC","HUVEC_Unstimulated"
"196","GSM141251","Human umbilical vein endothelial cells (HUVEC)","HUVEC_UnStim_B","HUVEC_UnStim_B"
"197","GSM141252","Human umbilical vein endothelial cells (HUVEC)","HUVEC_Bb_A","HUVEC_Bb_A"
"198","GSM141253","Human umbilical vein endothelial cells (HUVEC)","HUVEC_Bb_B","HUVEC_Bb_B"
"199","GSM141255","Human umbilical vein endothelial cells (HUVEC)","HUVEC_IFNg_B","HUVEC_IFNg_B"
"200","GSM143726","HUVEC Control_1 without stimulation","HUVEC control_1","HUVEC control_1"
"201","GSM143727","HUVEC Control_2 without stimulation","HUVEC control_2","HUVEC control_2"
"202","GSM143728","HUVEC SAA 20ug/ml 4h_1","HUVEC S4h_1","HUVEC S4h_1"
"203","GSM143729","HUVEC SAA 20ug/ml 4h_2","HUVEC S4h_2","HUVEC S4h_2"
"204","GSM143730","HUVEC SAA 20ug/ml 24h_1","HUVEC S24h_1","HUVEC S24h_1"
"205","GSM143731","HUVEC SAA 20ug/ml 24h_2","HUVEC S24h_2","HUVEC S24h_2"
"206","GSM143732","HUVEC SAA 20ug/ml 48h_1","HUVEC S48h_1","HUVEC S48h_1"
"207","GSM143733","HUVEC SAA 20ug/ml 48h_2","HUVEC S48h_2","HUVEC S48h_2"
"208","GSM143717","Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).","skin samples obtained healthy human donars during elective surgery at the Radcliffe Infirmary Hospital_Oxford (with full ethical approval)","Human lymphatic endothelial cells Control_Rep 1"
"209","GSM143898","Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).","Skin samples obtained from healthy human donors during elective surgery at the Radcliffe Infirmary Hospital_Oxford (with full ethical approval)","Human lymphatic endothelial cells Control_Rep 2"
"210","GSM143900","Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).","Skin samples obtained from healthy human donors during elective surgery at the Radcliffe Infirmary Hospital_Oxford (with full ethical approval)","Human lymphatic endothelial cells Control_Rep 3"
"211","GSM143907","Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).","Primary lymphatic endothelial cells cultured in vitro for 72h +/- TNFalpha derived from skin samples obtained from healthy human donors during elective surgery.","Human lymphatic endothelial cells TNFalpha_Rep 1"
"212","GSM143910","Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).","Primary lymphatic endothelial cells, cultured in vitro with TNFalpha, derived from skin samples obtained from healthy human donors during elective surgery.","Human lymphatic endothelial cells TNFalpha_Rep 2"
"213","GSM143914","Human dermal microvascular lymphatic endothelial cells (HDLEC) were prepared from healthy female adults undergoing elective surgery (breast reduction and abdominoplasty).","Primary lymphatic endothelial cells, cultured in vitro with TNFalpha, derived from skin samples obtained from healthy human donors during elective surgery.","Human lymphatic endothelial cells TNFalpha_Rep 3"
"214","GSM239606","Human iliac mesenchymal stem cells (MSC) were purchased from BioWhittaker Inc (Walkersville, MD) or obtained from iliac crest according to protocol approved by ethical authorities at Hiroshima University. Culture of MSC and their differentiation from the chondrocyte lineage were performed as described. (Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, et al. (2005) Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 20: 399-409.)","MSC_chondrogenesis","chondrocyte_rep1"
"215","GSM239612","Human iliac mesenchymal stem cells (MSC) were purchased from BioWhittaker Inc (Walkersville, MD) or obtained from iliac crest according to protocol approved by ethical authorities at Hiroshima University. Culture of MSC and their differentiation from the chondrocyte lineage were performed as described. (Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, et al. (2005) Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 20: 399-409.)","MSC_chondrogenesis","chondrocyte_rep2"
"216","GSM239613","Human iliac mesenchymal stem cells (MSC) were purchased from BioWhittaker Inc (Walkersville, MD) or obtained from iliac crest according to protocol approved by ethical authorities at Hiroshima University. Culture of MSC and their differentiation from the chondrocyte lineage were performed as described. (Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, et al. (2005) Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 20: 399-409.)","MSC_chondrogenesis","chondrocyte_rep3"
"217","GSM413840","c(\"disease group: normal\", \"cell type: chondrocytes\", \"cell culture: monolayer\")","human subcultured chondrocytes (passage 2) from normal donors","monolayer chondrocytes from normal donor 1"
"218","GSM413842","c(\"disease group: normal\", \"cell type: chondrocytes\", \"cell culture: monolayer\")","human subcultured chondrocytes (passage 2) from normal donors","monolayer chondrocytes from normal donor 3"
"219","GSM413846","c(\"disease group: normal\", \"cell type: chondrocytes\", \"cell culture: 3-D\")","human subcultured chondrocytes (passage 2) from normal donors maintained for 14 days in scaffold culture","3D-cultured chondrocytes from normal donor 1"
"220","GSM413847","c(\"disease group: normal\", \"cell type: chondrocytes\", \"cell culture: 3-D\")","human subcultured chondrocytes (passage 2) from normal donors maintained for 14 days in scaffold culture","3D-cultured chondrocytes from normal donor 2"
"221","GSM413848","c(\"disease group: normal\", \"cell type: chondrocytes\", \"cell culture: 3-D\")","human subcultured chondrocytes (passage 2) from normal donors maintained for 14 days in scaffold culture","3D-cultured chondrocytes from normal donor 3"
"222","GSM239616","Human iliac mesenchymal stem cells (MSC) were purchased from BioWhittaker Inc (Walkersville, MD) or obtained from iliac crest according to protocol approved by ethical authorities at Hiroshima University. Culture of MSC and their differentiation from the osteoblast lineage were performed as described. (Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, et al. (2005) Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 20: 399-409.)","MSC_osteogenesis","osteoblast_rep1"
"223","GSM239668","Human iliac mesenchymal stem cells (MSC) were purchased from BioWhittaker Inc (Walkersville, MD) or obtained from iliac crest according to protocol approved by ethical authorities at Hiroshima University. Culture of MSC and their differentiation from the osteoblast lineage were performed as described. (Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, et al. (2005) Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 20: 399-409.) ","MSC_osteogenesis","osteoblast_rep2"
"224","GSM239669","Human iliac mesenchymal stem cells (MSC) were purchased from BioWhittaker Inc (Walkersville, MD) or obtained from iliac crest according to protocol approved by ethical authorities at Hiroshima University. Culture of MSC and their differentiation from the osteoblast lineage were performed as described. (Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, et al. (2005) Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 20: 399-409.)","MSC_osteogenesis","osteoblast_rep3"
"225","GSM260311","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), Untreated 2h, biological replicate 1","HOb514_untreated_2h_rep1"
"226","GSM260312","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), Untreated 2h, biological replicate 2","HOb514_untreated_2h_rep2"
"227","GSM260313","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), Untreated 2h, biological replicate 3","HOb514_untreated_2h_rep3"
"228","GSM260308","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), BMP2 2h, biological replicate 1","HOb514_BMP2_2h_rep1"
"229","GSM260309","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), BMP2 2h, biological replicate 2","HOb514_BMP2_2h_rep2"
"230","GSM260310","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), BMP2 2h, biological replicate 3","HOb514_BMP2_2h_rep3"
"231","GSM260321","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), BMP2 24h, biological replicate 2","HOb514_BMP2_24h_rep2"
"232","GSM260305","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), untreated 24h, biological replicate 1","HOb514_untreated_24h_rep1"
"233","GSM260306","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), untreated 24h, biological replicate 2","HOb514_untreated_24h_rep2"
"234","GSM260307","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), untreated 24h, biological replicate 3","HOb514_untreated_24h_rep3"
"235","GSM260314","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), BMP2 24h, biological replicate 1","HOb514_BMP2_24h_rep1"
"236","GSM260322","HOb derived from trabecular bone explants, Gender: Male, Age:64","Primary human osteoblast like cells (HOb), BMP2 24h, biological replicate 3","HOb514_BMP2_24h_rep3"
"237","GSM456349","c(\"cell type: primary hepatocyte\", \"gender: female\")","Primary hepatocyte","Primary hepatocyte, biological replicate 1"
"238","GSM456350","c(\"cell type: primary hepatocyte\", \"gender: female\")","Primary hepatocyte","Primary hepatocyte, biological replicate 2"
"239","GSM456351","c(\"cell type: primary hepatocyte\", \"gender: female\")","Primary hepatocyte","Primary hepatocyte, biological replicate 3"
"240","GSM173532","Untreated","Normal human epidermal keratinocytes","Untreated PRB11895 (HGU133P)"
"241","GSM173533","Untreated","Normal human epidermal keratinocytes","Untreated PRB11896 (HGU133P)"
"242","GSM173534","Untreated","Normal human epidermal keratinocytes","Untreated PRB11897 (HGU133P)"
"243","GSM173535","Treated with IL19","Normal human epidermal keratinocytes","Treated with IL19 PRB11898 (HGU133P)"
"244","GSM173536","Treated with IL19","Normal human epidermal keratinocytes","Treated with IL19 PRB11899 (HGU133P)"
"245","GSM173537","Treated with IL19","Normal human epidermal keratinocytes","Treated with IL19 PRB11900 (HGU133P)"
"246","GSM173538","Treated with IL20","Normal human epidermal keratinocytes","Treated with IL20 PRB11901 (HGU133P)"
"247","GSM173539","Treated with IL20","Normal human epidermal keratinocytes","Treated with IL20 PRB11902 (HGU133P)"
"248","GSM173540","Treated with IL20","Normal human epidermal keratinocytes","Treated with IL20 PRB11903 (HGU133P)"
"249","GSM173541","Treated with IL22","Normal human epidermal keratinocytes","Treated with IL22 PRB11904 (HGU133P)"
"250","GSM173542","Treated with IL22","Normal human epidermal keratinocytes","Treated with IL22 PRB11905 (HGU133P)"
"251","GSM173543","Treated with IL22","Normal human epidermal keratinocytes","Treated with IL22 PRB11906 (HGU133P)"
"252","GSM173544","Treated with IL24","Normal human epidermal keratinocytes","Treated with IL24 PRB11907 (HGU133P)"
"253","GSM173545","Treated with IL24","Normal human epidermal keratinocytes","Treated with IL24 PRB11908 (HGU133P)"
"254","GSM173546","Treated with IL24","Normal human epidermal keratinocytes","Treated with IL24 PRB11909 (HGU133P)"
"255","GSM173547","Treated with IL26d","Normal human epidermal keratinocytes","Treated with IL26d PRB11910 (HGU133P)"
"256","GSM173548","Treated with IL26d","Normal human epidermal keratinocytes","Treated with IL26d PRB11911 (HGU133P)"
"257","GSM173549","Treated with IL26d","Normal human epidermal keratinocytes","Treated with IL26d PRB11912 (HGU133P)"
"258","GSM173550","Treated with KGF","Normal human epidermal keratinocytes","Treated with KGF PRB11913 (HGU133P)"
"259","GSM173551","Treated with KGF","Normal human epidermal keratinocytes","Treated with KGF PRB11914 (HGU133P)"
"260","GSM173552","Treated with KGF","Normal human epidermal keratinocytes","Treated with KGF PRB11915 (HGU133P)"
"261","GSM173553","Treated with IFNg","Normal human epidermal keratinocytes","Treated with IFNg PRB11916 (HGU133P)"
"262","GSM173554","Treated with IFNg","Normal human epidermal keratinocytes","Treated with IFNg PRB11917 (HGU133P)"
"263","GSM173555","Treated with IL1b","Normal human epidermal keratinocytes","Treated with IL1b PRB11919 (HGU133P)"
"264","GSM173556","Treated with IL1b","Normal human epidermal keratinocytes","Treated with IL1b PRB11920 (HGU133P)"
"265","GSM53382","NULL","Human Cell Line, adrenal medulla","Human Cell Line, adrenal medulla: RNA612_le1"
"266","GSM53383","NULL","Human Cell Line, adrenal medulla","Human Cell Line, adrenal medulla: RNA617_le1"
"267","GSM53384","NULL","Human Cell Line, adrenal medulla","Human Cell Line, adrenal medulla: RNA613_le1"
"268","GSM53385","NULL","Human Cell Line, adrenal medulla","Human Cell Line, adrenal medulla: RNA614_le1"
"269","GSM53386","NULL","Human Cell Line, adrenal medulla","Human Cell Line, adrenal medulla: RNA615_le1"
"270","GSM53387","NULL","Human Cell Line, adrenal medulla","Human Cell Line, adrenal medulla: RNA616_le1"
"271","GSM92231","NULL","nerve, HumanSuralNerve","nerve, HumanSuralNerve: Human Schwann cell RNA extracts 317 Passage 1_le1"
"272","GSM92232","NULL","nerve, HumanSuralNerve","nerve, HumanSuralNerve: Human Schwann cell RNA extracts 329 Passage 1_le1"
"273","GSM92233","NULL","nerve, HumanSuralNerve","nerve, HumanSuralNerve: Human Schwann cell RNA extracts 330 Passage 1_le1"
"274","GSM92234","NULL","nerve, HumanSuralNerve","nerve, HumanSuralNerve: Human Schwann cell RNA extracts 351 Passage 1_le1"
"275","GSM287216","c(\"Control\", \"Donor A\")","Untreated VSMCs","Donor A Untreated VSMCs"
"276","GSM287217","c(\"IL-17 treated\", \"Donor A\")","IL17-treated VSMCs","Donor A IL-17-treated VSMCs"
"277","GSM287218","c(\"Control\", \"Donor B\")","Untreated VSMCs","Donor B Untreated VSMCs"
"278","GSM287219","c(\"IL-17 treated\", \"Donor B\")","IL17-treated VSMCs","Donor B IL-17-treated VSMCs"
"279","GSM287220","c(\"Control\", \"Donor C\")","Untreated VSMCs","Donor C Untreated VSMCs"
"280","GSM287222","c(\"IL-17 treated\", \"Donor C\")","IL17-treated VSMCs","Donor C IL-17-treated VSMCs"
"281","GSM346959","Human vascular smooth muscle cell (VSMC)","Vascular smooth muscle control 24 hours","Smooth muscle cells  uninfected control, 24 hours,  biological rep 1"
"282","GSM346960","Human vascular smooth muscle cell (VSMC)","Vascular smooth muscle control 24 hours","Smooth muscle cells  uninfected control, 24 hours,  biological rep 2"
"283","GSM492834","c(\"developmental stage: mature\", \"cell type: Umbilical Vein Endothelial Cells\")","Human Umbilical Vein Smooth Muscle Cells cultured in serum free conditions for 48 hours","Human Umbilical Vein Smooth Muscle Cells_1"
"284","GSM492835","c(\"developmental stage: mature\", \"cell type: Umbilical Vein Endothelial Cells\")","Human Umbilical Vein Smooth Muscle Cells cultured in serum free conditions for 48 hours","Human Umbilical Vein Smooth Muscle Cells_2"
"285","GSM116101","c(\"ethnicity: Hispanic\", \"Gender: Male\", \"Age: 31\", \"Tissue: primary human bronchial smooth muscle cells\")","human bronchial smooth muscle cell_VitD_100nM_24h","hBSMC_vitamin D_rep1"
"286","GSM116102","c(\"ethnicity: Hispanic\", \"Gender: Male\", \"Age: 31\", \"Tissue: primary human bronchial smooth muscle cells\")","human bronchial smooth muscle cell_VitD_100nM_24h","hBSMC_vitamin D_rep2"
"287","GSM116103","c(\"ethnicity: Hispanic\", \"Gender: Male\", \"Age: 31\", \"Tissue: primary human bronchial smooth muscle cells\")","human bronchial smooth muscle cell_VitD_100nM_24h","hBSMC_vitamin D_rep3"
"288","GSM116104","c(\"ethnicity: Hispanic\", \"Gender: Male\", \"Age: 31\", \"Tissue: primary human bronchial smooth muscle cells\")","human bronchial smooth muscle cell_vehicle_24h","hBSMC_control_rep1"
"289","GSM116105","c(\"ethnicity: Hispanic\", \"Gender: Male\", \"Age: 31\", \"Tissue: primary human bronchial smooth muscle cells\")","human bronchial smooth muscle cell_vehicle_24h","hBSMC_control_rep2"
"290","GSM116106","c(\"ethnicity: Hispanic\", \"Gender: Male\", \"Age: 31\", \"Tissue: primary human bronchial smooth muscle cells\")","human bronchial smooth muscle cell_vehicle_24h","hBSMC_control_rep3"
"291","GSM178549","no additional information","peripheral blood, prior to G-CSF","Donor A, pre G-CSF"
"292","GSM178550","no additional information","peripheral blood, prior to G-CSF","Donor B, pre G-CSF"
"293","GSM178551","no additional information","peripheral blood, prior to G-CSF","Donor C, pre G-CSF"
"294","GSM178552","no additional information","peripheral blood, prior to G-CSF","Donor D, pre G-CSF"
"295","GSM178553","no additional information","peripheral blood, prior to G-CSF","Donor E, pre G-CSF"
"296","GSM178554","no additional information","peripheral blood, prior to G-CSF","Donor A, post G-CSF"
"297","GSM178555","no additional information","peripheral blood, prior to G-CSF","Donor B, post G-CSF"
"298","GSM178556","no additional information","peripheral blood, prior to G-CSF","Donor C, post G-CSF"
"299","GSM178557","no additional information","peripheral blood, prior to G-CSF","Donor D, post G-CSF"
"300","GSM178558","no additional information","peripheral blood, prior to G-CSF","Donor E, post G-CSF"
"301","GSM289612","Male","Human composite bone marrow, 2 months","human age 2 months"
"302","GSM289613","Female","Human composite bone marrow, 3 months","human age 3 months"
"303","GSM289614","Male","Human composite bone marrow, 9 months","human age 9 months"
"304","GSM289615","Male","Human composite bone marrow, 20 months","human age 20 months"
"305","GSM289616","Male","Human composite bone marrow, 23 months","human age 23 months"
"306","GSM289617","Male","Human composite bone marrow, 32 months","human age 32 months"
"307","GSM289618","Female","Human composite bone marrow, 39 months","human age 39 months"
"308","GSM483480","c(\"tissue type: bone marrow\", \"cell type: CD34+ hematopoietic stem cells (HSC)\", \"disease status: healthy control\")","Bone marrow CD34+ cells","Healthy control 1"
"309","GSM483481","c(\"tissue type: bone marrow\", \"cell type: CD34+ hematopoietic stem cells (HSC)\", \"disease status: healthy control\")","Bone marrow CD34+ cells","Healthy control 2"
"310","GSM483482","c(\"tissue type: bone marrow\", \"cell type: CD34+ hematopoietic stem cells (HSC)\", \"disease status: healthy control\")","Bone marrow CD34+ cells","Healthy control 3"
"311","GSM483483","c(\"tissue type: bone marrow\", \"cell type: CD34+ hematopoietic stem cells (HSC)\", \"disease status: healthy control\")","Bone marrow CD34+ cells","Healthy control 4"
"312","GSM483484","c(\"tissue type: bone marrow\", \"cell type: CD34+ hematopoietic stem cells (HSC)\", \"disease status: healthy control\")","Bone marrow CD34+ cells","Healthy control 5"
"313","GSM483485","c(\"tissue type: bone marrow\", \"cell type: CD34+ hematopoietic stem cells (HSC)\", \"disease status: healthy control\")","Bone marrow CD34+ cells","Healthy control 6"
"314","GSM488968","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal CMP cells\")","Normal CMP cells","Flow sorted normal CMP cells, 1"
"315","GSM488969","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal CMP cells\")","Normal CMP cells","Flow sorted normal CMP cells, 2"
"316","GSM488970","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal GMP cells\")","Normal GMP cells","Flow sorted normal GMP cells, 1"
"317","GSM488971","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal GMP cells\")","Normal GMP cells","Flow sorted normal GMP cells, 2"
"318","GSM488974","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal MEP cells\")","Normal MEP cells","Flow sorted normal MEP cells, 1"
"319","GSM488975","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal MEP cells\")","Normal MEP cells","Flow sorted normal MEP cells, 2"
"320","GSM488976","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal Myelocytes\")","Normal Myelocytes","Flow sorted normal Myelocytes, 1"
"321","GSM488977","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal Myelocytes\")","Normal Myelocytes","Flow sorted normal Myelocytes, 2"
"322","GSM488982","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal Pro-Myelocytes\")","Normal Pro-Myelocytes","Flow sorted normal Pro-Myelocytes, 1"
"323","GSM488983","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal Pro-Myelocytes\")","Normal Pro-Myelocytes","Flow sorted normal Pro-Myelocytes, 2"
"324","GSM488978","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal Pre-B cells\")","Normal Pre-B cells","Flow sorted normal Pre-B cells, 1"
"325","GSM488979","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal Pre-B cells\")","Normal Pre-B cells","Flow sorted normal Pre-B cells, 2"
"326","GSM488980","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal Pro-B cells\")","Normal Pro-B cells","Flow sorted normal Pro-B cells, 1"
"327","GSM488981","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal Pro-B cells\")","Normal Pro-B cells","Flow sorted normal Pro-B cells, 2"
"328","GSM488972","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal immature B-cells\")","Normal immature B-cells","Flow sorted normal immature B-cells, 1"
"329","GSM488973","c(\"tissue: normal flow sorted bone marrow\", \"cell type: Normal immature B-cells\")","Normal immature B-cells","Flow sorted normal immature B-cells, 2"
"330","GSM290414","Tissue: peripheral blood, Subject:Healthy Control","platelet from control","platelet_Ctrl_1"
"331","GSM290415","Tissue: peripheral blood, Subject:Healthy Control","platelet from control","platelet_Ctrl_2"
"332","GSM290420","Tissue: peripheral blood, Subject:Healthy Control","platelet from control","platelet_Ctrl_7"
"333","GSM290421","Tissue: peripheral blood, Subject:Healthy Control","platelet from control","platelet_Ctrl_8"
"334","GSM290423","Tissue: peripheral blood, Subject:Healthy Control","platelet from control","platelet_Ctrl_10"
"335","GSM469125","c(\"developmental stage: 9-14 week old fetus\", \"cell type: mesenchymal stem cells\", \"tissue: blood\")","Human fetal material, 9-14 weeks, from legal abortions.","Blood_1"
"336","GSM469136","c(\"developmental stage: 9-14 week old fetus\", \"cell type: mesenchymal stem cells\", \"tissue: blood\")","Human fetal material, 9-14 weeks, from legal abortions.","Blood_2"
"337","GSM469126","c(\"developmental stage: 9-14 week old fetus\", \"cell type: mesenchymal stem cells\", \"tissue: blood\")","Human fetal material, 9-14 weeks, from legal abortions.","Blood_3"
"338","GSM469127","c(\"developmental stage: 9-14 week old fetus\", \"cell type: mesenchymal stem cells\", \"tissue: bone marrow\")","Human fetal material, 9-14 weeks, from legal abortions.","Bone Marrow_1"
"339","GSM469128","c(\"developmental stage: 9-14 week old fetus\", \"cell type: mesenchymal stem cells\", \"tissue: bone marrow\")","Human fetal material, 9-14 weeks, from legal abortions.","Bone Marrow_2"
"340","GSM469129","c(\"developmental stage: 9-14 week old fetus\", \"cell type: mesenchymal stem cells\", \"tissue: bone marrow\")","Human fetal material, 9-14 weeks, from legal abortions.","Bone Marrow_3"
"341","GSM469130","c(\"developmental stage: 9-14 week old fetus\", \"cell type: mesenchymal stem cells\", \"tissue: liver\")","Human fetal material, 9-14 weeks, from legal abortions.","Liver_1"
"342","GSM469131","c(\"developmental stage: 9-14 week old fetus\", \"cell type: mesenchymal stem cells\", \"tissue: liver\")","Human fetal material, 9-14 weeks, from legal abortions.","Liver_2"
"343","GSM469132","c(\"developmental stage: 9-14 week old fetus\", \"cell type: mesenchymal stem cells\", \"tissue: liver\")","Human fetal material, 9-14 weeks, from legal abortions.","Liver_3"
"344","GSM556647","c(\"cell type: Monocyte\", \"stress: unstimulated\")","Monocyte","Monocyte No Stim 1"
"345","GSM556663","c(\"cell type: Monocyte\", \"stress: unstimulated\")","Monocyte","Monocyte No Stim 2"
"346","GSM556665","c(\"cell type: Monocyte\", \"stress: stimulated with Flagellin\")","Monocyte","Monocyte Stimulated 1"
"347","GSM182002","CD14+ Macs bead separated  monocytes","B240 Monocytes treated with isotype control antibody for 24 hrs","B240 monocytes treated with isotype control antibody for 24 hrs"
"348","GSM182003","CD14+ macs bead separated monocytes","B307 Monocytes treated with isotype control antibody","B307 Monocytes treated with isotype control antibody for 24 hrs"
"349","GSM182000","CD14+ Macs bead separated monocytes","B239 Monocytes treated with isotype control antibody","B239 Monocytes treated with isotype control antibody for 24 hrs"
"350","GSM182001","CD14+ macs bead separated monocytes","B239 monocytes traeted with anti-FcgRIIB antibody ","B239 monocytes treated with anti-FcgRIIB antibody for 24 hrs"
"351","GSM182004","CD14+ macs bead seperated monocytes","B307 Monocytes treated with anti-FcgRIIB antibody","B307 Monocytes treated with anti-FcgRIIB antibody for 24 hrs"
"352","GSM189447","Monocytes exposed to vehicle control (EtOH)","Human elutriated monocytes","Donor 1 - control"
"353","GSM189448","Monocytes exposed to vehicle control (EtOH)","Human elutriated monocytes","Donor 2 - control"
"354","GSM189449","Monocytes exposed to vehicle control (EtOH)","Human elutriated monocytes","Donor 3 - control"
"355","GSM189450","Monocytes exposed to vehicle control (EtOH)","Human elutriated monocytes","Donor 4 - control"
"356","GSM189451","Monocytes stimulated with LTD4 (100nM) for 30 min.","Human elutriated monocytes","Donor 1 - LTD4 stimulated"
"357","GSM189452","Monocytes stimulated with LTD4 (100nM) for 30 min.","Human elutriated monocytes","Donor 2 - LTD4 stimulated"
"358","GSM189453","Monocytes stimulated with LTD4 (100nM) for 30 min.","Human elutriated monocytes","Donor 3 - LTD4 stimulated"
"359","GSM189454","Monocytes stimulated with LTD4 (100nM) for 30 min.","Human elutriated monocytes","Donor 4 - LTD4 stimulated"
"360","GSM305430","healthy adult","peripheral blood monocytes","Uninfected D1_UT"
"361","GSM305432","healthy adult","peripheral blood monocytes","Uninfected D2_UT"
"362","GSM305433","healthy adult","peripheral blood monocytes","F. novicida infected D3_FN"
"363","GSM305434","healthy adult","peripheral blood monocytes","Uninfected D3_UT"
"364","GSM305435","healthy adult","peripheral blood monocytes","F. novicida infected D4_FN"
"365","GSM305436","healthy adult","peripheral blood monocytes","Uninfected D4_UT"
"366","GSM305437","healthy adult","peripheral blood monocytes","Schu S4 infected D5_S4"
"367","GSM305438","healthy adult","peripheral blood monocytes","Uninfected D5_UT"
"368","GSM305440","healthy adult","peripheral blood monocytes","Uninfected D6_UT"
"369","GSM305441","healthy adult","peripheral blood monocytes","Schu S4 infected D7_S4"
"370","GSM305442","healthy adult","peripheral blood monocytes","Schu S4 infected D8_S4"
"371","GSM305439","healthy adult","peripheral blood monocytes","Schu S4 infected D6_S4"
"372","GSM350084","female","CD14+ monocytes, by positive selection","CD14+ at baseline, biological replicate 1"
"373","GSM350085","male","CD14+ monocytes, by positive selection","CD14+ at baseline, biological replicate 2"
"374","GSM350086","female","CD14+ monocytes, by positive selection","CD14+ at baseline, biological replicate 3"
"375","GSM422109","c(\"donor health: healthy\", \"tissue: peripheral blood\", \"cell type: monocyte\", \"cd16: negative\")","peripheral blood monocytes, CD16-","Peripheral blood monocytes, CD16 negative, rep1"
"376","GSM422110","c(\"donor health: healthy\", \"tissue: peripheral blood\", \"cell type: monocyte\", \"cd16: negative\")","peripheral blood monocytes, CD16-","Peripheral blood monocytes, CD16 negative, rep2"
"377","GSM422111","c(\"donor health: healthy\", \"tissue: peripheral blood\", \"cell type: monocyte\", \"cd16: negative\")","peripheral blood monocytes, CD16-","Peripheral blood monocytes, CD16 negative, rep3"
"378","GSM422112","c(\"donor health: healthy\", \"tissue: peripheral blood\", \"cell type: monocyte\", \"cd16: negative\")","peripheral blood monocytes, CD16-","Peripheral blood monocytes, CD16 negative, rep4"
"379","GSM422113","c(\"donor health: healthy\", \"tissue: peripheral blood\", \"cell type: monocyte\", \"cd16: positive\")","peripheral blood monocytes, CD16+","Peripheral blood monocytes, CD16 positive, rep1"
"380","GSM422114","c(\"donor health: healthy\", \"tissue: peripheral blood\", \"cell type: monocyte\", \"cd16: positive\")","peripheral blood monocytes, CD16+","Peripheral blood monocytes, CD16 positive, rep2"
"381","GSM422116","c(\"donor health: healthy\", \"tissue: peripheral blood\", \"cell type: monocyte\", \"cd16: positive\")","peripheral blood monocytes, CD16+","Peripheral blood monocytes, CD16 positive, rep4"
"382","GSM432175","monocyte subsets: CD16- monocytes","human CD16- monocytes","CD16- 1"
"383","GSM432176","monocyte subsets: CD16- monocytes","human CD16- monocytes","CD16- 2"
"384","GSM432177","monocyte subsets: CD16- monocytes","human CD16- monocytes","CD16- 3"
"385","GSM432178","monocyte subsets: CD16+ monocytes","human CD16+ monocytes","CD16+ 1"
"386","GSM432179","monocyte subsets: CD16+ monocytes","human CD16+ monocytes","CD16+ 2"
"387","GSM432180","monocyte subsets: CD16+ monocytes","human CD16+ monocytes","CD16+ 3"
"388","GSM140244","c(\"cell type: monocyte\", \"disease state: control participant\")","human CD14 positive monopcytes","control participant P303"
"389","GSM140245","c(\"cell type: monocyte\", \"disease state: control participant\")","human CD14 positive monopcytes","control participant P307"
"390","GSM140246","c(\"cell type: monocyte\", \"disease state: control participant\")","human CD14 positive monopcytes","control participant P309"
"391","GSM140247","c(\"cell type: monocyte\", \"disease state: control participant\")","human CD14 positive monopcytes","control participant P311"
"392","GSM140248","c(\"cell type: monocyte\", \"disease state: control participant\")","human CD14 positive monopcytes","control participant P313"
"393","GSM140249","c(\"cell type: monocyte\", \"disease state: control participant\")","human CD14 positive monopcytes","control participant P317"
"394","GSM514669","c(\"cell type: primary human monocyte-derived macrophages\", \"differentiation factor: MCSF\")","primary human monocyte-derived macrophages","MCSF_A"
"395","GSM514670","c(\"cell type: primary human monocyte-derived macrophages\", \"differentiation factor: MCSF\")","primary human monocyte-derived macrophages","MCSF_B"
"396","GSM514671","c(\"cell type: primary human monocyte-derived macrophages\", \"differentiation factor: CXCL4\")","primary human monocyte-derived macrophages","CXCL4_A"
"397","GSM514672","c(\"cell type: primary human monocyte-derived macrophages\", \"differentiation factor: CXCL4\")","primary human monocyte-derived macrophages","CXCL4_B"
"398","GSM183165","Macrophages differentiated in the presence of IL-4 for 5 days ","Macrophages","Macrophages IL-4 - control BC348.1"
"399","GSM183193","Macrophages differentiated in the presence of IL-4 for 5 days","Macrophages","Macrophages IL-4 - control BC348.3"
"400","GSM183196","Macrophages differentiated in the presence of IL-4 for 5 days","Macrophages","Macrophages IL-4 - control BC349.4"
"401","GSM183201","Macrophages differentiated in the presence of IL-4 for 5 days","Macrophages","Macrophages IL-4 - control BC350.3"
"402","GSM183209","Macrophages differentiated in the presence of IL-4 for 5 days","Macrophages","Macrophages IL-4 - control BC351.2"
"403","GSM183217","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days","Macrophages","Macrophages IL-4 Dex - control BC284.1"
"404","GSM183305","Macrophages differentiated in the presence of IL-4 adn dexamethasone for 5 days","Macrophages","Macrophages IL-4 Dex - control BC284.2"
"405","GSM183306","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days","Macrophages","Macrophages IL-4 Dex - control BC286.2"
"406","GSM183315","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days","Macrophages","Macrophages IL-4 Dex - control BC287.3"
"407","GSM183316","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days","Macrophages","Macrophages IL-4 Dex - control BC296.3"
"408","GSM183392","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 3h","Macrophages","Macrophages IL-4 Dex TGF-beta 3h BC284.1"
"409","GSM183393","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 3h","Macrophages","Macrophages IL-4 Dex TGF-beta 3h BC284.2"
"410","GSM183394","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 3h","Macrophages","Macrophages IL-4 Dex TGF-beta 3h BC286.2"
"411","GSM183462","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 3h","Macrophages","Macrophages IL-4 Dex TGF-beta 3h BC287.3"
"412","GSM183463","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 3h","Macrophages","Macrophages IL-4 Dex TGF-beta 3h BC296.3"
"413","GSM183464","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 Dex TGF-beta 24h BC284.1"
"414","GSM183465","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 Dex TGF-beta 24h BC284.2"
"415","GSM183466","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 Dex TGF-beta 24h BC286.2"
"416","GSM183467","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 Dex TGF-beta 24h BC287.3"
"417","GSM183482","Macrophages differentiated in the presence of IL-4 and dexamethasone for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 Dex TGF-beta 24h BC296.3"
"418","GSM183483","Macrophages differentiated in the presence of IL-4 for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 - TGF 24h BC348.1"
"419","GSM183484","Macrophages differentiated in the presence of IL-4 for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 - TGF 24h BC348.3"
"420","GSM183485","Macrophages differentiated in the presence of IL-4 for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 - TGF 24h BC349.4"
"421","GSM183486","Macrophages differentiated in the presence of IL-4 for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 - TGF 24h BC350.3"
"422","GSM183487","Macrophages differentiated in the presence of IL-4 for 5 days and then stimulated by TGF-beta for 24h","Macrophages","Macrophages IL-4 - TGF 24h BC351.2"
"423","GSM299556","Peripheral blood from healthy human donor","Donor 1, fresh monocytes","Donor 1, fresh monocytes"
"424","GSM299561","Peripheral blood from healthy human donor","Donor 2, fresh monocytes","Donor 2, fresh monocytes"
"425","GSM299557","Peripheral blood from healthy human donor","Donor 1, M-CSF","Donor 1, M-CSF"
"426","GSM299562","Peripheral blood from healthy human donor","Donor 2, M-CSF","Donor 2, M-CSF"
"427","GSM299558","Peripheral blood from healthy human donor","Donor 1, M-CSF + IFN-gamma","Donor 1, M-CSF + IFN-gamma"
"428","GSM299563","Peripheral blood from healthy human donor","Donor 2, M-CSF + IFN-gamma","Donor 2, M-CSF + IFN-gamma"
"429","GSM299559","Peripheral blood from healthy human donor","Donor 1, M-CSF + Pam3Cys","Donor 1, M-CSF + Pam3Cys"
"430","GSM299564","Peripheral blood from healthy human donor","Donor 2, M-CSF + Pam3Cys","Donor 2, M-CSF + Pam3Cys"
"431","GSM299560","Peripheral blood from healthy human donor","Donor 1, M-CSF + IFN-gamma + Pam3Cys","Donor 1, M-CSF + IFN-gamma + Pam3Cys"
"432","GSM299565","Peripheral blood from healthy human donor","Donor 2, M-CSF + IFN-gamma + Pam3Cys","Donor 2, M-CSF + IFN-gamma + Pam3Cys"
"433","GSM300389","Control #1, IFN treated","Macrophages derived from pheripheral blood","C1 Control IFN"
"434","GSM300390","Control #5, IFN treated","Macrophages derived from pheripheral blood","C5 Control IFN"
"435","GSM300392","Control #2, IFN treated","Macrophages derived from pheripheral blood","C2 Control IFN"
"436","GSM300393","Control #3, IFN treated","Macrophages derived from pheripheral blood","C3 Control IFN"
"437","GSM300394","Control #6, IFN treated","Macrophages derived from pheripheral blood","C6 Control IFN"
"438","GSM300395","Control #4, IFN treated","Macrophages derived from pheripheral blood","C4 Control IFN"
"439","GSM300398","Control #1, Untreated","Macrophages derived from pheripheral blood","C1 Control None"
"440","GSM300399","Control #5, Untreated","Macrophages derived from pheripheral blood","C5 Control None"
"441","GSM300401","Control #2, Untreated","Macrophages derived from pheripheral blood","C2 Control None"
"442","GSM300402","Control #3, Untreated","Macrophages derived from pheripheral blood","C3 Control None"
"443","GSM300403","Control #6, Untreated","Macrophages derived from pheripheral blood","C6 Control None"
"444","GSM300404","Control #4, Untreated","Macrophages derived from pheripheral blood","C4 Control None"
"445","GSM343810","control hMDMs","human monocyte-derived macrophages, control, 24hr, replicate 2","hMDM_control_24hr_2"
"446","GSM343828","control hMDMs","human monocyte-derived macrophages, control, 24hr, replicate 5","hMDM_control_24hr_5"
"447","GSM343802","control hMDMs","human monocyte-derived macrophages, control, 8hr, replicate 1","hMDM_control_8hr_1"
"448","GSM343808","control hMDMs","human monocyte-derived macrophages, control, 8hr, replicate 2","hMDM_control_8hr_2"
"449","GSM343814","control hMDMs","human monocyte-derived macrophages, control, 8hr, replicate 3","hMDM_control_8hr_3"
"450","GSM343820","control hMDMs","human monocyte-derived macrophages, control, 8hr, replicate 4","hMDM_control_8hr_4"
"451","GSM343826","control hMDMs","human monocyte-derived macrophages, control, 8hr, replicate 5","hMDM_control_8hr_5"
"452","GSM343804","control hMDMs","human monocyte-derived macrophages, control, 24hr, replicate 1","hMDM_control_24hr_1"
"453","GSM343816","control hMDMs","human monocyte-derived macrophages, control, 24hr, replicate 3","hMDM_control_24hr_3"
"454","GSM343822","control hMDMs","human monocyte-derived macrophages, control, 24hr, replicate 4","hMDM_control_24hr_4"
"455","GSM343806","control hMDMs","human monocyte-derived macrophages, control, 48hr, replicate 1","hMDM_control_48hr_1"
"456","GSM343812","control hMDMs","human monocyte-derived macrophages, control, 48hr, replicate 2","hMDM_control_48hr_2"
"457","GSM343818","control hMDMs","human monocyte-derived macrophages, control, 48hr, replicate 3","hMDM_control_48hr_3"
"458","GSM343824","control hMDMs","human monocyte-derived macrophages, control, 48hr, replicate 4","hMDM_control_48hr_4"
"459","GSM343830","control hMDMs","human monocyte-derived macrophages, control, 48hr, replicate 5","hMDM_control_48hr_5"
"460","GSM343803","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 8hr, replicate 1","hMDM_SA_8hr_1"
"461","GSM343809","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 8hr, replicate 2","hMDM_SA_8hr_2"
"462","GSM343815","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 8hr, replicate 3","hMDM_SA_8hr_3"
"463","GSM343821","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 8hr, replicate 4","hMDM_SA_8hr_4"
"464","GSM343827","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 8hr, replicate 5","hMDM_SA_8hr_5"
"465","GSM343805","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 24hr, replicate 1","hMDM_SA_24hr_1"
"466","GSM343811","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 24hr, replicate 2","hMDM_SA_24hr_2"
"467","GSM343817","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 24hr, replicate 3","hMDM_SA_24hr_3"
"468","GSM343823","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 24hr, replicate 4","hMDM_SA_24hr_4"
"469","GSM343829","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 24hr, replicate 5","hMDM_SA_24hr_5"
"470","GSM343807","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 48hr, replicate 1","hMDM_SA_48hr_1"
"471","GSM343813","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 48hr, replicate 2","hMDM_SA_48hr_2"
"472","GSM343819","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 48hr, replicate 3","hMDM_SA_48hr_3"
"473","GSM343825","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 48hr, replicate 4","hMDM_SA_48hr_4"
"474","GSM343831","SA-treated hMDMs","human monocyte-derived macrophages, S. aureus-treated, 48hr, replicate 5","hMDM_SA_48hr_5"
"475","GSM359332","c(\"Preparation of Bacillus anthracis spores\", \"B. anthracis, Sterne strain 7702 (pX01+, pX02-), was kindly provided by Dr. Jimmy Ballard (University of Oklahoma Health Sciences Center, Oklahoma City).  Bacteria were grown overnight at 37<U+F0B0>C with continuous shaking in LB media and were then streaked onto AK Agar sporulating slants.  Bacteria were incubated for three weeks at 30<U+F0B0>C.  The slants were washed with 10ml of chilled, sterile, deionized water and spun at 10,000 x g for 10 minutes and resuspended in 10ml chilled water.  The spore suspension was heated at 65<U+F0B0>C degrees for 30 minutes to kill vegetative bacteria.  After heat treatment the spores were centrifuged for 10 minutes at 10,000 x g.  The supernatant and the very top layer of the pellet were aspirated and then the spores were resuspended in chilled sterile deionized water and centrifuged for 10 minutes.  The pellet was washed 5 times to remove contaminating cell debris.  The titer of the spore preparation was determined by plate counts.  The spores were diluted to 1 X 109 spores/ml and stored at 4<U+F0B0>C. Titers were reconfirmed by plate counts before each use.  There was no detectable endotoxin in the final spore dilutions used in the experiments as determined by limulus amebocyte lysate assay (Cambrex, Walkersville, MD).\", 
\"Collection of human alveolar macrophages\", \"Macrophages were obtained by bronchoscopy with the consent of human subjects following a protocol approved by the Oklahoma University Health Sciences Center Institutional Review Board and the Institutional Biosafety Committee.  These volunteers were healthy subjects with no smoking history or history of pulmonary disease.  Cells were collected in sterile saline solution from human subjects and centrifuged at 500 x g for five minutes.  The supernatant was removed and the pellets were washed in 10ml of RPMI-1640 containing 50É g/ml gentamicin and resuspended in 10ml RPMI + 2% fetal calf serum (FCS) with 50É g/ml gentamicin.  Cell counts were determined by a hemocytometer; cell type was determined by morphology using Diff-Quick staining (Baxter, Miami, FL); and cells were resuspended to a concentration of 1 X 106 macrophages/ml.  There were >95% macrophages in each cell preparation. One ml of cells per well was plated into 24 well plates and allowed to incubate for 2 to 4 h to facilitate attachment.  Subsequently, the media was removed and fresh media containing 2% FCS and gentamicin was added.  The cells were incubated overnight at 37<U+F0B0>C with 5% CO2.\"
)","Human alveolar macrophages","mock transfected, array 1"
"476","GSM359753","c(\"Preparation of Bacillus anthracis spores\", \"B. anthracis, Sterne strain 7702 (pX01+, pX02-), was kindly provided by Dr. Jimmy Ballard (University of Oklahoma Health Sciences Center, Oklahoma City).  Bacteria were grown overnight at 37<U+F0B0>C with continuous shaking in LB media and were then streaked onto AK Agar sporulating slants.  Bacteria were incubated for three weeks at 30<U+F0B0>C.  The slants were washed with 10ml of chilled, sterile, deionized water and spun at 10,000 x g for 10 minutes and resuspended in 10ml chilled water.  The spore suspension was heated at 65<U+F0B0>C degrees for 30 minutes to kill vegetative bacteria.  After heat treatment the spores were centrifuged for 10 minutes at 10,000 x g.  The supernatant and the very top layer of the pellet were aspirated and then the spores were resuspended in chilled sterile deionized water and centrifuged for 10 minutes.  The pellet was washed 5 times to remove contaminating cell debris.  The titer of the spore preparation was determined by plate counts.  The spores were diluted to 1 X 109 spores/ml and stored at 4<U+F0B0>C. Titers were reconfirmed by plate counts before each use.  There was no detectable endotoxin in the final spore dilutions used in the experiments as determined by limulus amebocyte lysate assay (Cambrex, Walkersville, MD).\", 
\"Collection of human alveolar macrophages\", \"Macrophages were obtained by bronchoscopy with the consent of human subjects following a protocol approved by the Oklahoma University Health Sciences Center Institutional Review Board and the Institutional Biosafety Committee.  These volunteers were healthy subjects with no smoking history or history of pulmonary disease.  Cells were collected in sterile saline solution from human subjects and centrifuged at 500 x g for five minutes.  The supernatant was removed and the pellets were washed in 10ml of RPMI-1640 containing 50É g/ml gentamicin and resuspended in 10ml RPMI + 2% fetal calf serum (FCS) with 50É g/ml gentamicin.  Cell counts were determined by a hemocytometer; cell type was determined by morphology using Diff-Quick staining (Baxter, Miami, FL); and cells were resuspended to a concentration of 1 X 106 macrophages/ml.  There were >95% macrophages in each cell preparation. One ml of cells per well was plated into 24 well plates and allowed to incubate for 2 to 4 h to facilitate attachment.  Subsequently, the media was removed and fresh media containing 2% FCS and gentamicin was added.  The cells were incubated overnight at 37<U+F0B0>C with 5% CO2.\"
)","Human alveolar macrophages","mock transfected, array 2"
"477","GSM359754","c(\"Preparation of Bacillus anthracis spores\", \"B. anthracis, Sterne strain 7702 (pX01+, pX02-), was kindly provided by Dr. Jimmy Ballard (University of Oklahoma Health Sciences Center, Oklahoma City).  Bacteria were grown overnight at 37<U+F0B0>C with continuous shaking in LB media and were then streaked onto AK Agar sporulating slants.  Bacteria were incubated for three weeks at 30<U+F0B0>C.  The slants were washed with 10ml of chilled, sterile, deionized water and spun at 10,000 x g for 10 minutes and resuspended in 10ml chilled water.  The spore suspension was heated at 65<U+F0B0>C degrees for 30 minutes to kill vegetative bacteria.  After heat treatment the spores were centrifuged for 10 minutes at 10,000 x g.  The supernatant and the very top layer of the pellet were aspirated and then the spores were resuspended in chilled sterile deionized water and centrifuged for 10 minutes.  The pellet was washed 5 times to remove contaminating cell debris.  The titer of the spore preparation was determined by plate counts.  The spores were diluted to 1 X 109 spores/ml and stored at 4<U+F0B0>C. Titers were reconfirmed by plate counts before each use.  There was no detectable endotoxin in the final spore dilutions used in the experiments as determined by limulus amebocyte lysate assay (Cambrex, Walkersville, MD).\", 
\"Collection of human alveolar macrophages\", \"Macrophages were obtained by bronchoscopy with the consent of human subjects following a protocol approved by the Oklahoma University Health Sciences Center Institutional Review Board and the Institutional Biosafety Committee.  These volunteers were healthy subjects with no smoking history or history of pulmonary disease.  Cells were collected in sterile saline solution from human subjects and centrifuged at 500 x g for five minutes.  The supernatant was removed and the pellets were washed in 10ml of RPMI-1640 containing 50É g/ml gentamicin and resuspended in 10ml RPMI + 2% fetal calf serum (FCS) with 50É g/ml gentamicin.  Cell counts were determined by a hemocytometer; cell type was determined by morphology using Diff-Quick staining (Baxter, Miami, FL); and cells were resuspended to a concentration of 1 X 106 macrophages/ml.  There were >95% macrophages in each cell preparation. One ml of cells per well was plated into 24 well plates and allowed to incubate for 2 to 4 h to facilitate attachment.  Subsequently, the media was removed and fresh media containing 2% FCS and gentamicin was added.  The cells were incubated overnight at 37<U+F0B0>C with 5% CO2.\"
)","Human alveolar macrophages","mock transfected, array 3"
"478","GSM359755","c(\"Preparation of Bacillus anthracis spores\", \"B. anthracis, Sterne strain 7702 (pX01+, pX02-), was kindly provided by Dr. Jimmy Ballard (University of Oklahoma Health Sciences Center, Oklahoma City).  Bacteria were grown overnight at 37<U+F0B0>C with continuous shaking in LB media and were then streaked onto AK Agar sporulating slants.  Bacteria were incubated for three weeks at 30<U+F0B0>C.  The slants were washed with 10ml of chilled, sterile, deionized water and spun at 10,000 x g for 10 minutes and resuspended in 10ml chilled water.  The spore suspension was heated at 65<U+F0B0>C degrees for 30 minutes to kill vegetative bacteria.  After heat treatment the spores were centrifuged for 10 minutes at 10,000 x g.  The supernatant and the very top layer of the pellet were aspirated and then the spores were resuspended in chilled sterile deionized water and centrifuged for 10 minutes.  The pellet was washed 5 times to remove contaminating cell debris.  The titer of the spore preparation was determined by plate counts.  The spores were diluted to 1 X 109 spores/ml and stored at 4<U+F0B0>C. Titers were reconfirmed by plate counts before each use.  There was no detectable endotoxin in the final spore dilutions used in the experiments as determined by limulus amebocyte lysate assay (Cambrex, Walkersville, MD).\", 
\"Collection of human alveolar macrophages\", \"Macrophages were obtained by bronchoscopy with the consent of human subjects following a protocol approved by the Oklahoma University Health Sciences Center Institutional Review Board and the Institutional Biosafety Committee.  These volunteers were healthy subjects with no smoking history or history of pulmonary disease.  Cells were collected in sterile saline solution from human subjects and centrifuged at 500 x g for five minutes.  The supernatant was removed and the pellets were washed in 10ml of RPMI-1640 containing 50É g/ml gentamicin and resuspended in 10ml RPMI + 2% fetal calf serum (FCS) with 50É g/ml gentamicin.  Cell counts were determined by a hemocytometer; cell type was determined by morphology using Diff-Quick staining (Baxter, Miami, FL); and cells were resuspended to a concentration of 1 X 106 macrophages/ml.  There were >95% macrophages in each cell preparation. One ml of cells per well was plated into 24 well plates and allowed to incubate for 2 to 4 h to facilitate attachment.  Subsequently, the media was removed and fresh media containing 2% FCS and gentamicin was added.  The cells were incubated overnight at 37<U+F0B0>C with 5% CO2.\"
)","Human alveolar macrophages","mock transfected, array 4"
"479","GSM359758","c(\"Preparation of Bacillus anthracis spores\", \"B. anthracis, Sterne strain 7702 (pX01+, pX02-), was kindly provided by Dr. Jimmy Ballard (University of Oklahoma Health Sciences Center, Oklahoma City).  Bacteria were grown overnight at 37<U+F0B0>C with continuous shaking in LB media and were then streaked onto AK Agar sporulating slants.  Bacteria were incubated for three weeks at 30<U+F0B0>C.  The slants were washed with 10ml of chilled, sterile, deionized water and spun at 10,000 x g for 10 minutes and resuspended in 10ml chilled water.  The spore suspension was heated at 65<U+F0B0>C degrees for 30 minutes to kill vegetative bacteria.  After heat treatment the spores were centrifuged for 10 minutes at 10,000 x g.  The supernatant and the very top layer of the pellet were aspirated and then the spores were resuspended in chilled sterile deionized water and centrifuged for 10 minutes.  The pellet was washed 5 times to remove contaminating cell debris.  The titer of the spore preparation was determined by plate counts.  The spores were diluted to 1 X 109 spores/ml and stored at 4<U+F0B0>C. Titers were reconfirmed by plate counts before each use.  There was no detectable endotoxin in the final spore dilutions used in the experiments as determined by limulus amebocyte lysate assay (Cambrex, Walkersville, MD).\", 
\"Collection of human alveolar macrophages\", \"Macrophages were obtained by bronchoscopy with the consent of human subjects following a protocol approved by the Oklahoma University Health Sciences Center Institutional Review Board and the Institutional Biosafety Committee.  These volunteers were healthy subjects with no smoking history or history of pulmonary disease.  Cells were collected in sterile saline solution from human subjects and centrifuged at 500 x g for five minutes.  The supernatant was removed and the pellets were washed in 10ml of RPMI-1640 containing 50É g/ml gentamicin and resuspended in 10ml RPMI + 2% fetal calf serum (FCS) with 50É g/ml gentamicin.  Cell counts were determined by a hemocytometer; cell type was determined by morphology using Diff-Quick staining (Baxter, Miami, FL); and cells were resuspended to a concentration of 1 X 106 macrophages/ml.  There were >95% macrophages in each cell preparation. One ml of cells per well was plated into 24 well plates and allowed to incubate for 2 to 4 h to facilitate attachment.  Subsequently, the media was removed and fresh media containing 2% FCS and gentamicin was added.  The cells were incubated overnight at 37<U+F0B0>C with 5% CO2.\"
)","Human alveolar macrophages infected by B. antracis spore","spore transfected, array 1"
"480","GSM359759","c(\"Preparation of Bacillus anthracis spores\", \"B. anthracis, Sterne strain 7702 (pX01+, pX02-), was kindly provided by Dr. Jimmy Ballard (University of Oklahoma Health Sciences Center, Oklahoma City).  Bacteria were grown overnight at 37<U+F0B0>C with continuous shaking in LB media and were then streaked onto AK Agar sporulating slants.  Bacteria were incubated for three weeks at 30<U+F0B0>C.  The slants were washed with 10ml of chilled, sterile, deionized water and spun at 10,000 x g for 10 minutes and resuspended in 10ml chilled water.  The spore suspension was heated at 65<U+F0B0>C degrees for 30 minutes to kill vegetative bacteria.  After heat treatment the spores were centrifuged for 10 minutes at 10,000 x g.  The supernatant and the very top layer of the pellet were aspirated and then the spores were resuspended in chilled sterile deionized water and centrifuged for 10 minutes.  The pellet was washed 5 times to remove contaminating cell debris.  The titer of the spore preparation was determined by plate counts.  The spores were diluted to 1 X 109 spores/ml and stored at 4<U+F0B0>C. Titers were reconfirmed by plate counts before each use.  There was no detectable endotoxin in the final spore dilutions used in the experiments as determined by limulus amebocyte lysate assay (Cambrex, Walkersville, MD).\", 
\"Collection of human alveolar macrophages\", \"Macrophages were obtained by bronchoscopy with the consent of human subjects following a protocol approved by the Oklahoma University Health Sciences Center Institutional Review Board and the Institutional Biosafety Committee.  These volunteers were healthy subjects with no smoking history or history of pulmonary disease.  Cells were collected in sterile saline solution from human subjects and centrifuged at 500 x g for five minutes.  The supernatant was removed and the pellets were washed in 10ml of RPMI-1640 containing 50É g/ml gentamicin and resuspended in 10ml RPMI + 2% fetal calf serum (FCS) with 50É g/ml gentamicin.  Cell counts were determined by a hemocytometer; cell type was determined by morphology using Diff-Quick staining (Baxter, Miami, FL); and cells were resuspended to a concentration of 1 X 106 macrophages/ml.  There were >95% macrophages in each cell preparation. One ml of cells per well was plated into 24 well plates and allowed to incubate for 2 to 4 h to facilitate attachment.  Subsequently, the media was removed and fresh media containing 2% FCS and gentamicin was added.  The cells were incubated overnight at 37<U+F0B0>C with 5% CO2.\"
)","Human alveolar macrophages infected by B. antracis spore","spore transfected, array 2"
"481","GSM359760","c(\"Preparation of Bacillus anthracis spores\", \"B. anthracis, Sterne strain 7702 (pX01+, pX02-), was kindly provided by Dr. Jimmy Ballard (University of Oklahoma Health Sciences Center, Oklahoma City).  Bacteria were grown overnight at 37<U+F0B0>C with continuous shaking in LB media and were then streaked onto AK Agar sporulating slants.  Bacteria were incubated for three weeks at 30<U+F0B0>C.  The slants were washed with 10ml of chilled, sterile, deionized water and spun at 10,000 x g for 10 minutes and resuspended in 10ml chilled water.  The spore suspension was heated at 65<U+F0B0>C degrees for 30 minutes to kill vegetative bacteria.  After heat treatment the spores were centrifuged for 10 minutes at 10,000 x g.  The supernatant and the very top layer of the pellet were aspirated and then the spores were resuspended in chilled sterile deionized water and centrifuged for 10 minutes.  The pellet was washed 5 times to remove contaminating cell debris.  The titer of the spore preparation was determined by plate counts.  The spores were diluted to 1 X 109 spores/ml and stored at 4<U+F0B0>C. Titers were reconfirmed by plate counts before each use.  There was no detectable endotoxin in the final spore dilutions used in the experiments as determined by limulus amebocyte lysate assay (Cambrex, Walkersville, MD).\", 
\"Collection of human alveolar macrophages\", \"Macrophages were obtained by bronchoscopy with the consent of human subjects following a protocol approved by the Oklahoma University Health Sciences Center Institutional Review Board and the Institutional Biosafety Committee.  These volunteers were healthy subjects with no smoking history or history of pulmonary disease.  Cells were collected in sterile saline solution from human subjects and centrifuged at 500 x g for five minutes.  The supernatant was removed and the pellets were washed in 10ml of RPMI-1640 containing 50É g/ml gentamicin and resuspended in 10ml RPMI + 2% fetal calf serum (FCS) with 50É g/ml gentamicin.  Cell counts were determined by a hemocytometer; cell type was determined by morphology using Diff-Quick staining (Baxter, Miami, FL); and cells were resuspended to a concentration of 1 X 106 macrophages/ml.  There were >95% macrophages in each cell preparation. One ml of cells per well was plated into 24 well plates and allowed to incubate for 2 to 4 h to facilitate attachment.  Subsequently, the media was removed and fresh media containing 2% FCS and gentamicin was added.  The cells were incubated overnight at 37<U+F0B0>C with 5% CO2.\"
)","Human alveolar macrophages infected by B. antracis spore","spore transfected, array 3"
"482","GSM419987","c(\"cell type: monocyte-derived macrophage\", \"agent: control\")","primary macrophages, control","control cell donor 1"
"483","GSM419988","c(\"cell type: monocyte-derived macrophage\", \"agent: control\")","primary macrophages, control","control cell donor 2"
"484","GSM419989","c(\"cell type: monocyte-derived macrophage\", \"agent: control\")","primary macrophages, control","control cell donor 3"
"485","GSM419990","c(\"cell type: monocyte-derived macrophage\", \"agent: IFNalpha\")","primary macrophages, IFNa-treated","IFNa treated donor 1"
"486","GSM419991","c(\"cell type: monocyte-derived macrophage\", \"agent: IFNalpha\")","primary macrophages, IFNa-treated","IFNa treated donor 2"
"487","GSM419992","c(\"cell type: monocyte-derived macrophage\", \"agent: IFNalpha\")","primary macrophages, IFNa-treated","IFNa treated donor 3"
"488","GSM181857","monocyte derived DCs","immature DCs without IFN alpha treatment 24 hrs","B304 immature DCs no interferon alpha treatment"
"489","GSM181931","monocyte derived DCs","Immature Dcs without IFN alpha treatment","B305 immature DCs without IFN alpha treatment"
"490","GSM181933","monocyte derived DCs","Immature Dcs without IFN alpha treatment","Immature DCs without IFN alpha treatment"
"491","GSM181930","monocyte derived Dcs","b304 immature dcs with ifn alpha treatment 24 hrs","B304 immature Dcs IFN alpha treatment"
"492","GSM181932","monocyte derived DCs","Immature DCs treated with IFNalpha","B305 Immature DCs treated with IFNa "
"493","GSM181934","monocyte derived DCs","Immature Dcs treated with IFN alpha","Immature Dcs treated with IFN alpha"
"494","GSM181982","monocyte derived DCs","B195 Immature Dcs treated with isotype control antibody","B226 immature DCs treated with isotype control antibody"
"495","GSM181997","monocyte derived DCs","B227 Immature DCs treated with isotype control antibody","B227 immature DCs treated with isotype control antibody for 24 hrs"
"496","GSM181972","monocyte derived DCs","131 immature DCs treated with anti-FcgRIIb antibody for 24 hrs","131 Immature DCs treated with anti-FcgRIIB antibody for 24 hrs"
"497","GSM181983","monocyte derived DCs","B226 Immature DCs treated with anti-FcgRIIB antibody","B226 Immature DCs treated with anti-FcgRIIB antibody for 24 hrs"
"498","GSM181998","monocyte derived DCs","B227 Immature Dcs treated with anti-FcgRIIB antibody","B227 immature DCs treated with anti- FcgRIIB antibody for 24 hrs"
"499","GSM181984","monocyte derived DCs","B226 Immature DCs treated with inflammatory cytokines","B226 Immature DCs treated with inflammatory cytokines for 24 hrs"
"500","GSM181999","monocyte derived DCs","B227 immature DCs treated with inflammatory cytokines","B227 immature DCs treated with inflammatory cytokines for 24 hrs"
"501","GSM181971","monocyte derived DCs","Isotype treated immature Dcs","B131 isotype treated DCs"
"502","GSM181973","monocyte derived DCs","Immature DCs treated with isotype control antibody for 24 hrs","B158 DCs treated with isotype antibody"
"503","GSM181978","monocyte derived DCs","B195 DCs treated with isotype control antibody for 24 hrs","B195 DCs treated with isotype control antibody for 24 hrs"
"504","GSM181974","monocyte derived DCs","B158 DCs treated with anti-FcgRIIB antibody for 24 hrs","B158 DCs treated with anti-FcgRIIB antibody for 24 hrs"
"505","GSM181980","monocyte derived DCs","B195 DCs treated with anti-FcgRIIB antibody for 24 hrs","B195 DCs treated with anti-FCgRIIB antibody for 24 hrs"
"506","GSM181976","monocyte derived DCs","B158 DCs treated with inflammatory cytokines for 24 hrs","B158 DCs treated with inflammatory cytokines for 24 hrs"
"507","GSM181981","monocyte derived DCs","B195 DCs treated with inflammatory cytokines for 24 hrs","B195 DCs treated with inflammatory cytokines for 24 hrs"
"508","GSM286088","Monocyte derived dendritic cells from a healthy donor, unstimulated control analyzed after 6h hours","dendritic cells_unstimulated control_6h","iDC_6h"
"509","GSM286089","Monocyte derived dendritic cells from a healthy donor, unstimulated control analyzed after 12 hours","dendritic cells_unstimulated control_12h","iDC_12h"
"510","GSM286090","Monocyte derived dendritic cells from a healthy donor, unstimulated control analyzed after 24 hours","dendritic cells_unstimulated control_24h","iDC_24h"
"511","GSM286091","Monocyte derived dendritic cells from a healthy donor, unstimulated control analyzed after 48 hours","dendritic cells_unstimulated control_48h","iDC_48h"
"512","GSM286015","monocyte derived dendritic cells from a healthy donor activated for 6 hours with LPS IFNg analyzed after 6 hours","dendritic cells_LPS IFNg_6h","6h_LPS_IFNg"
"513","GSM286017","monocyte derived dendritic cells from a healthy donor activated for 6 hours with LPS IFNg analyzed after 12 hours","dendritic cells_LPS IFNg_12h","12h_LPS_IFNg"
"514","GSM286086","monocyte derived dendritic cells from a healthy donor activated for 6 hours with LPS IFNg analyzed after 24 hours","dendritic cells_LPS IFNg_24h","24h_LPS_IFNg"
"515","GSM286087","Monocyte derived dendritic cells from a healthy donor activated for 6 hours with LPS IFNg analyzed after 48 hours","dendritic cells_LPS IFNg_48h","48h_LPS_IFNg"
"516","GSM320543","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 1 Day 5 MDDC differentiated without AEC\")","control MDDC, day 5","Sample 1 control MDDC, day 5"
"517","GSM320545","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 2 Day 5 MDDC differentiated without AEC\")","control MDDC, day 5","Sample 2 control MDDC, day 5"
"518","GSM320547","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 3 Day 5 MDDC differentiated without AEC\")","control MDDC, day 5","Sample 3 control MDDC, day 5"
"519","GSM320549","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 4 Day 5 MDDC differentiated without AEC\")","control MDDC, day 5","Sample 4 control MDDC, day 5"
"520","GSM320551","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 5 Day 5 MDDC differentiated without AEC\")","control MDDC, day 5","Sample 5 control MDDC, day 5"
"521","GSM320544","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 1 Day 5 MDDC differentiated without AEC\")","AEC-conditioned MDDC, day 5","Sample 1 AEC-conditioned MDDC, day 5"
"522","GSM320546","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 2 Day 5 MDDC differentiated without AEC\")","AEC-conditioned MDDC, day 5","Sample 2 AEC-conditioned MDDC, day 5"
"523","GSM320548","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 3 Day 5 MDDC differentiated without AEC\")","AEC-conditioned MDDC, day 5","Sample 3 AEC-conditioned MDDC, day 5"
"524","GSM320550","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 4 Day 5 MDDC differentiated without AEC\")","AEC-conditioned MDDC, day 5","Sample 4 AEC-conditioned MDDC, day 5"
"525","GSM320552","c(\"CD14+ monocytes obtained from the peripheral blood of atopic adults\", \"Sample 5 Day 5 MDDC differentiated without AEC\")","AEC-conditioned MDDC, day 5","Sample 5 AEC-conditioned MDDC, day 5"
"526","GSM260689","healthy donor","unstimulated monocyte-derived dendritic cells","Immature dendritic cells unstimulated"
"527","GSM260691","healthy donor","monocyte-derived dendritic cells 8 hours after stimulation with LPS","Dendritic cells after LPS treatment, time point 8 hours"
"528","GSM260692","healthy donor","monocyte-derived dendritic cells 16 hours after stimulation with LPS","Dendritic cells after LPS treatment, time point 16 hours"
"529","GSM260693","healthy donor","monocyte-derived dendritic cells 4 hours after stimulation with Poly(I:C)","Dendritic cells after Poly(I:C) treatment, time point 4 hours"
"530","GSM260694","healthy donor","monocyte-derived dendritic cells 8 hours after stimulation with Poly(I:C)","Dendritic cells after Poly(I:C) treatment, time point 8 hours"
"531","GSM260695","healthy donor","monocyte-derived dendritic cells 16 hours after stimulation with Poly(I:C)","Dendritic cells after Poly(I:C) treatment, time point 16 hours"
"532","GSM260696","healthy donor","monocyte-derived dendritic cells 4 hours after stimulation with CD40L","Dendritic cells after CD40L treatment, time point 4 hours"
"533","GSM260697","healthy donor","monocyte-derived dendritic cells 8 hours after stimulation with CD40L","Dendritic cells after CD40L treatment, time point 8 hours"
"534","GSM260698","healthy donor","monocyte-derived dendritic cells 16 hours after stimulation with CD40L","Dendritic cells after CD40L treatment, time point 16 hours"
"535","GSM260699","healthy donor","monocyte-derived dendritic cells 4 hours after combined treatment with IL-1-b, IL-6, TNF-a and PGE2","Dendritic cells after Schuler treatment, time point 4 hours"
"536","GSM260700","healthy donor","monocyte-derived dendritic cells 8 hours after combined treatment with IL-1-b, IL-6, TNF-a and PGE2","Dendritic cells after Schuler treatment, time point 8 hours"
"537","GSM260701","healthy donor","monocyte-derived dendritic cells 16 hours after combined treatment with IL-1-b, IL-6, TNF-a and PGE2","Dendritic cells after Schuler treatment, time point 16 hours"
"538","GSM260690","healthy donor","monocyte-derived dendritic cells 4 hours after stimulation with LPS","Dendritic cells after LPS treatment, time point 4hours"
"539","GSM112490","immature MDDCs","monocyte derived dendritic cells","untreated DONOR 1"
"540","GSM112491","immature monocyte derived dendritic cells","monocyte derived dendritic cells","untreated DONOR 2"
"541","GSM112540","immatured monocyte derived dendritic cells","monocyte derived dendritic cells","untreated DONOR 3"
"542","GSM112541","galectin-1 matured MDDCs","monocyte derived dendritic cells","Galectin-1 DONOR 1"
"543","GSM112661","galectin-1 matured dendritic cells","monocyte derived dendritic cells","Galectin-1 DONOR 2"
"544","GSM112664","galectin-1 matured MDDCs","monocyte derived dendritic cells","Galectin-1 DONOR 3"
"545","GSM112665","LPS matured MDDCs","monocyte derived dendritic cells","LPS DONOR 1"
"546","GSM112666","LPS matured MDDCs","monocyte derived dendritic cells","LPS DONOR 2"
"547","GSM112667","LPS matured MDDCs","monocyte derived dendritic cells","LPS DONOR 3"
"548","GSM112668","MDDCS treated with vehicle only","monocyte derived dendritic cells","Vehicle Control DONOR 1"
"549","GSM112669","MDDCS treated with vehicle only","monocyte derived dendritic cells","Vehicle Control DONOR 2"
"550","GSM112670","MDDCS treated with vehicle only","monocyte derived dendritic cells","Vehicle Control DONOR 3"
"551","GSM132919","c(\"tissue: freshly isolated human monocyte\", \"gender:female; age: 19 yr; weight: 65 kg\")","Monocyte derived dendritic cells","DC1"
"552","GSM132923","c(\"tissue: freshly isolated human monocyte\", \"gender:male; age: 47 yr; weight: 80 kg\")","Monocyte derived dendritic cells","DC2"
"553","GSM132927","c(\"tissue: freshly isolated human monocyte\", \"gender:male; age: 41 yr; weight: 92 kg\")","Monocyte derived dendritic cells","DC3"
"554","GSM132921","c(\"tissue: freshly isolated human monocyte\", \"gender:female; age: 19 yr; weight: 65 kg\")","Monocyte derived dendritic cells","DC1 RSG"
"555","GSM132924","c(\"tissue: freshly isolated human monocyte\", \"gender:male; age: 47 yr; weight: 80 kg\")","Monocyte derived dendritic cells","DC2 RSG"
"556","GSM132928","c(\"tissue: freshly isolated human monocyte\", \"gender:male; age: 41 yr; weight: 92 kg\")","Monocyte derived dendritic cells","DC3 RSG"
"557","GSM132922","c(\"tissue: freshly isolated human monocyte\", \"gender:female; age: 19 yr; weight: 65 kg\")","Monocyte derived dendritic cells","DC1 AM"
"558","GSM132925","c(\"tissue: freshly isolated human monocyte\", \"gender:male; age: 47 yr; weight: 80 kg\")","Monocyte derived dendritic cells","DC2 AM"
"559","GSM132929","c(\"tissue: freshly isolated human monocyte\", \"gender:male; age: 41 yr; weight: 92 kg\")","Monocyte derived dendritic cells","DC3 AM"
"560","GSM132926","c(\"tissue: freshly isolated human monocyte\", \"gender:male; age: 47 yr; weight: 80 kg\")","Monocyte derived dendritic cells","DC2 RSG AGN"
"561","GSM132930","c(\"tissue: freshly isolated human monocyte\", \"gender:male; age: 41 yr; weight: 92 kg\")","Monocyte derived dendritic cells","DC3 RSG AGN"
"562","GSM264755","c(\"8h, stimulated, not treated\", \"Donor D1_ctrl\")","immature human monocyte-derived dendritic cells (MoDCs)","hMoDC_stim_8h_ctrl_rep1"
"563","GSM264756","c(\"8h, stimulated, not treated\", \"Donor D2_ctrl\")","immature human monocyte-derived dendritic cells (MoDCs)","hMoDC_stim_8h_ctrl_rep2"
"564","GSM264757","c(\"8h, stimulated, treated with VAF347\", \"Donor D1_VAF347\")","immature human monocyte-derived dendritic cells (MoDCs)","hMoDC_stim_8h_VAF347_rep1"
"565","GSM264758","c(\"8h, stimulated, treated with VAF347\", \"Donor D2_VAF347\")","immature human monocyte-derived dendritic cells (MoDCs)","hMoDC_stim_8h_VAF347_rep2"
"566","GSM140953","Buffy coats were obtained from the National Blood Centre. Circulating myeloid DCs were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.","primary dendritic cells (DCs)","DC_Unstimulated_Rep1"
"567","GSM140968","Buffy coats were obtained from the National Blood Centre. Circulating myeloid DCs were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.","primary dendritic cells (DCs)","DC_Unstimulated_Rep2"
"568","GSM140969","Buffy coats were obtained from the National Blood Centre. Circulating myeloid dendritic cells (DCs) were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.","primary dendritic cells (DCs)","DC_Unstimulated_Rep3"
"569","GSM140970","Buffy coats were obtained from the National Blood Centre. Circulating myeloid dendritic cells (DCs) were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.","primary dendritic cells (DCs)","DC_Stimulated_Rep1"
"570","GSM140971","Buffy coats were obtained from the National Blood Centre. Circulating myeloid dendritic cells (DCs) were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.","primary dendritic cells (DCs)","DC_Stimulated_Rep2"
"571","GSM140973","Buffy coats were obtained from the National Blood Centre. Circulating myeloid dendritic cells (DCs) were isolated from buffy coats by adherence and culture in IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). DC preparations analyzed were more than 98% pure.","primary dendritic cells (DCs)","DC_Stimulated_Rep3"
"572","GSM160530","Buffy Coat blood of healthy donors","Immature dendritic cells cultivated in medium for 6h","Dendritic cells generated from blood of donor 1"
"573","GSM160534","Buffy Coat blood of healthy donors","Immature dendritic cells cultivated in medium for 6h","Dendritic cells generated from blood of donor 2"
"574","GSM160536","Buffy Coat blood of healthy donors","Immature dendritic cells cultivated together with Aspergillus fumigatus germ tubes for 6h","Dendritic cells generated from blood of donor 2 + A. fumigatus germ tubes"
"575","GSM160532","Buffy Coat blood of healthy donors","Immature dendritic cells cultivated together with Aspergillus fumigatus germ tubes for 6h","Dendritic cells generated from blood of donor 1 + A. fumigatus germ tubes"
"576","GSM279581","c(\"cell type: Naive\", \"sample type: purified cells\", \"fractional abundance: 0.1306\")","Naive, donor 121704","Naive, donor 121704"
"577","GSM279582","c(\"cell type: Naive\", \"sample type: purified cells\", \"fractional abundance: 0.1436\")","Naive, donor 11405","Naive, donor 11405"
"578","GSM279583","c(\"cell type: Naive\", \"sample type: purified cells\", \"fractional abundance: 0.1191\")","Naive, donor 12405","Naive, donor 12405"
"579","GSM279584","c(\"cell type: Naive\", \"sample type: purified cells\", \"fractional abundance: 0.193\")","Naive, donor 12805","Naive, donor 12805"
"580","GSM279572","c(\"cell type: Central memory\", \"sample type: purified cells\", \"fractional abundance: NA\")","Central memory, donor 120604","Central memory, donor 120604"
"581","GSM279573","c(\"cell type: Central memory\", \"sample type: purified cells\", \"fractional abundance: 0.1662\")","Central memory, donor 121704","Central memory, donor 121704"
"582","GSM279574","c(\"cell type: Central memory\", \"sample type: purified cells\", \"fractional abundance: 0.0955\")","Central memory, donor 11405","Central memory, donor 11405"
"583","GSM279575","c(\"cell type: Central memory\", \"sample type: purified cells\", \"fractional abundance: 0.1193\")","Central memory, donor 12405","Central memory, donor 12405"
"584","GSM279576","c(\"cell type: Central memory\", \"sample type: purified cells\", \"fractional abundance: 0.0764\")","Central memory, donor 12805","Central memory, donor 12805"
"585","GSM279577","c(\"cell type: Effector memory\", \"sample type: purified cells\", \"fractional abundance: 0.0278\")","Effector memory, donor 121704","Effector memory, donor 121704"
"586","GSM279578","c(\"cell type: Effector memory\", \"sample type: purified cells\", \"fractional abundance: 0.042\")","Effector memory, donor 11405","Effector memory, donor 11405"
"587","GSM279579","c(\"cell type: Effector memory\", \"sample type: purified cells\", \"fractional abundance: 0.0399\")","Effector memory, donor 12405","Effector memory, donor 12405"
"588","GSM279580","c(\"cell type: Effector memory\", \"sample type: purified cells\", \"fractional abundance: 0.0283\")","Effector memory, donor 12805","Effector memory, donor 12805"
"589","GSM372800","c(\"age: 30\", \"gender: Male\", \"t_cell_purity: 89%\")","CD4 T cells, Negative Selection","N_CD4_1"
"590","GSM372801","c(\"age: 44\", \"gender: Female\", \"t_cell_purity: 95.50%\")","CD4 T cells, Negative Selection","N_CD4_2"
"591","GSM372802","c(\"age: 47\", \"gender: Female\", \"t_cell_purity: 92%\")","CD4 T cells, Negative Selection","N_CD4_3"
"592","GSM372803","c(\"age: 33\", \"gender: Female\", \"t_cell_purity: 94%\")","CD4 T cells, Negative Selection","N_CD4_4"
"593","GSM372804","c(\"age: 44\", \"gender: Male\", \"t_cell_purity: 94%\")","CD4 T cells, Negative Selection","N_CD4_5"
"594","GSM372805","c(\"age: 44\", \"gender: Female\", \"t_cell_purity: 96.30%\")","CD4 T cells, Positive Selection","P_CD4_6"
"595","GSM372806","c(\"age: 47\", \"gender: Female\", \"t_cell_purity: 97.50%\")","CD4 T cells, Positive Selection","P_CD4_7"
"596","GSM372807","c(\"age: 33\", \"gender: Female\", \"t_cell_purity: 90%\")","CD4 T cells, Positive Selection","P_CD4_8"
"597","GSM372808","c(\"age: 27\", \"gender: Female\", \"t_cell_purity: 92%\")","CD4 T cells, Positive Selection","P_CD4_10"
"598","GSM372809","c(\"age: 35\", \"gender: Male\", \"t_cell_purity: 91%\")","CD8 T cells, Negative Selection","N_CD8_1"
"599","GSM372810","c(\"age: 33\", \"gender: Male\", \"t_cell_purity: 88%\")","CD8 T cells, Negative Selection","N_CD8_2"
"600","GSM372811","c(\"age: 37\", \"gender: Male\", \"t_cell_purity: 83%\")","CD8 T cells, Negative Selection","N_CD8_3"
"601","GSM372812","c(\"age: 33\", \"gender: Female\", \"t_cell_purity: 87%\")","CD8 T cells, Negative Selection","N_CD8_4"
"602","GSM372813","c(\"age: 44\", \"gender: Male\", \"t_cell_purity: 76%\")","CD8 T cells, Negative Selection","N_CD8_5"
"603","GSM372814","c(\"age: 37\", \"gender: Male\", \"t_cell_purity: 94.10%\")","CD8 T cells, Positive Selection","P_CD8_7"
"604","GSM372815","c(\"age: 44\", \"gender: Male\", \"t_cell_purity: 89.50%\")","CD8 T cells, Positive Selection","P_CD8_8"
"605","GSM372816","c(\"age: 33\", \"gender: Female\", \"t_cell_purity: 93.30%\")","CD8 T cells, Positive Selection","P_CD8_9"
"606","GSM372817","c(\"age: 31\", \"gender: Male\", \"t_cell_purity: 89%\")","CD8 T cells, Positive Selection","P_CD8_10"
"607","GSM372818","c(\"age: 31\", \"gender: Male\", \"t_cell_purity: 87%\")","CD8 T cells, Positive Selection","P_CD8_11"
"608","GSM349848","Gamma-delta T cells obtained from a healthy voulenter.","Control","normal gamma-delta T cell duplicate 1"
"609","GSM349849","Gamma-delta T cells obtained from a healthy voulenter.","Control","normal gamma-delta T cell duplicate 2"
"610","GSM547998","cell type: nTreg","Unstimulated Treg cells sorted from the the PBMC of a healthy human sample, replicate 1","Unstimulated nTreg cells, replicate 1"
"611","GSM547999","cell type: nTreg","Unstimulated Treg cells sorted from the the PBMC of a healthy human sample, replicate 2","Unstimulated nTreg cells, replicate 2"
"612","GSM548000","cell type: naive CD4","Unstimulated naive CD4 cells sorted from the the PBMC of a healthy human sample, replicate 1","Unstimulated naive CD4 cells replicate 1"
"613","GSM548001","cell type: naive CD4","Unstimulated naive CD4 cells sorted from the the PBMC of a healthy human sample, replicate 2","Unstimulated naive CD4 cells replicate 2"
"614","GSM153893","Human naive T cells were cultured in 96-well plate coated with anti-CD3 and anti-CD28 antibodies in RPMI medium supplemented with 10% FBS and retinoid acid.  After culture for 6 days, T cells were sorted based on expression of alpha4beta7 integrin.","human peripheral naive T cells","Retinoid Acid stimulated T effector cells"
"615","GSM154073","24-well plates were coated with anti-CD3 and anti-CD28 monoclonal antibodies (1 É g/ml) in phosphate buffered saline overnight at 4 ÅãC. Naive T cells (0.7 x 10E6/well) were cultured in RPMI-1640 (GIBCO) supplemented with 10% heat-inactivated FCS, penicillin/streptomycin and glutamine (all from GIBCO), in the absence of cholecalciferol (vitamin D3), 25-hydroxyvitamin D3 (25(OH)D3), 1alpha-25-hydroxyvitamin D3 (1,25(OH)2D3), or all-trans retinoic acid (all from Sigma-Aldrich), and without 2.5<U+2013>10 ng/ml of IL-12 (R&D Systems). After 2 days, T cells were transferred to a new plate, and fresh medium containing IL-2 (12.5 ng/ml) was added and cultured for 4 additional days.  This is called unstimulated T effector cells, which was sorted based on expression of alpha4beta7 integrin (intermediate level) and CD3 marker.","human peripheral naive T cells","Unstimulated T effector cells"
"616","GSM154077","24-well plates were coated with anti-CD3 and anti-CD28 monoclonal antibodies (1 É g/ml) in phosphate buffered saline overnight at 4 ÅãC. Naive or memory T cells (0.7 x 106/well) were cultured in RPMI-1640 (GIBCO) supplemented with 10% heat-inactivated FCS, penicillin/streptomycin and glutamine (all from GIBCO), in the presence of 10 ng/ml of IL-12 (R&D Systems). After 2 days, T cells were transferred to a new plate, and fresh medium containing IL-2 (12.5 ng/ml) and IL-12 (2.5 ng/ml) added and cultured for 4 additional days.  T effector cells were FACS-sorted based on expression of cutaneous lymphocyte antigen expression and CD3 positive.","human peripheral naive T cells","IL-12 stimulated T effector cells"
"617","GSM154078","24-well plates were coated with anti-CD3 and anti-CD28 monoclonal antibodies (1 É g/ml) in phosphate buffered saline overnight at 4 ÅãC. Naive or memory T cells (0.7 x 106/well) were cultured in RPMI-1640 (GIBCO) supplemented with 10% heat-inactivated FCS, penicillin/streptomycin and glutamine (all from GIBCO), in the presence of 1alpha-25-hydroxyvitamin D3 (1,25(OH)2D3) (from Sigma-Aldrich), but without 10 ng/ml of IL-12 (R&D Systems). After 2 days, T cells were transferred to a new plate, and fresh medium containing IL-2 (12.5 ng/ml) was added and the cells were cultured for 4 additional days.  T effector cellls were FACS-sorted based on expression of cutaneous lymphocyte antigen (CLA) and CD3 marker.","human peripheral naive T cells","1,25(OH)2 vitamin D3 stimulated T effector cells"
"618","GSM154081","24-well plates were coated with anti-CD3 and anti-CD28 monoclonal antibodies (1 É g/ml) in phosphate buffered saline overnight at 4 ÅãC. Naive or memory T cells (0.7 x 106/well) were cultured in RPMI-1640 (GIBCO) supplemented with 10% heat-inactivated FCS, penicillin/streptomycin and glutamine (all from GIBCO), in the presence of 1alpha-25-hydroxyvitamin D3 (1,25(OH)2D3) from Sigma-Aldrich, and with 10 ng/ml of IL-12 (R&D Systems). After 2 days, T cells were transferred to a new plate, and fresh medium containing IL-2 (12.5 ng/ml) and IL-12 (2.5 ng/ml) added and cultured for 4 additional days.  The cells were FACS-sorted based on expression of CCR10-positive and CLA-positive.","human peripheral naive T cells","1,25(OH)2 vitamin D3 plus IL-12 stimulated CCR10-positive CLA-positive T cells"
"619","GSM154084","24-well plates were coated with anti-CD3 and anti-CD28 monoclonal antibodies (1 É g/ml) in phosphate buffered saline overnight at 4 ÅãC. Naive or memory T cells (0.7 x 106/well) were cultured in RPMI-1640 (GIBCO) supplemented with 10% heat-inactivated FCS, penicillin/streptomycin and glutamine (all from GIBCO), in the presence of 1alpha-25-hydroxyvitamin D3 (1,25(OH)2D3 with 10 ng/ml of IL-12 (R&D Systems). After 2 days, T cells were transferred to a new plate, and fresh medium containing IL-2 (12.5 ng/ml) and IL-12 (2.5 ng/ml) added and cultured for 4 additional days.  The cells were FACS-sorted based on expression of CLA-positive but CCR10-negative.","human peripheral naive T cells","1,25(OH)2 vitamin D3 plus IL-12 stimulated CCR10-negative CLA-positive T cells"
"620","GSM198942","Natural Killer cells isolated from peripheral blood of healthy individuals","Natural Killer cells","Resting_NK"
"621","GSM198943","Primary NK cells were isolated from  healthy donors and  peripheral blood mononuclear cells (PBMCs)  were isolated by Ficoll-Hypaque density gradient centrifugation at room temperature.  Purified NK cells were cultured in RPMI 1640 medium (Life Technologies, New York, NY) supplemented with 10% fetal bovine serum, 200 ug/ml streptomycin and 200 IU/ml penicillin, and IL2 (100 IU/ml) for 2 hours at 37oC and 5% CO2, before harvest and storage in Trizol at -80ÅãC till RNA isolation. ","Natural killer cells","NK_time2hours"
"622","GSM198944","Primary NK cells were isolated from healthy donors and peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque density gradient centrifugation at room temperature.  Purified NK cells were cultured in RPMI 1640 medium (Life Technologies, New York, NY) supplemented with 10% fetal bovine serum, 200 ug/ml streptomycin and 200 IU/ml penicillin, and IL2 (100 IU/ml) for 8 hours at 37oC and 5% CO2, before harvest and storage in Trizol at -80ÅãC till RNA isolation.","Natural killer cells","NK_timepoint8hours"
"623","GSM198945","Primary NK cells were isolated from healthy donors and peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque density gradient centrifugation at room temperature.  Purified NK cells were cultured in RPMI 1640 medium (Life Technologies, New York, NY) supplemented with 10% fetal bovine serum, 200 ug/ml streptomycin and 200 IU/ml penicillin, and IL2 (100 IU/ml) for 24 hours at 37oC and 5% CO2, before harvest and storage in Trizol at -80ÅãC till RNA isolation.","Natural killer cells","NK_timepoint24hours"
"624","GSM542578","cell type: CD3- CD56bright CD62L+ NK cells","CD62L+CD56brightCD3-, CD62L+CD56dimCD3- and CD62L-CD56dimCD3- NK cells from human peripheral blood","CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells Group1 ND1"
"625","GSM361266","Neutrophils were isolated from blood provided by unknown donors.","neutrophils, non stimulated, 30min","PMN_ctrl_30min"
"626","GSM361272","Neutrophils were isolated from blood provided by unknown donors.","neutrophils, stimulated, 30min","PMN_inflam_30min"
"627","GSM361278","Neutrophils were isolated from blood provided by unknown donors.","neutrophils, stimulated, 30min","PMN_inflam+CGS_30min"
"628","GSM361283","Neutrophils were isolated from blood provided by unknown donors.","neutrophils, stimulated, 30min","PMN_inflam+PGE2_30min"
"629","GSM361285","Neutrophils were isolated from blood provided by unknown donors.","neutrophils, stimulated, 30min","PMN_inflam+RO+F_30min"
"630","GSM466518","c(\"gender: male\", \"cell type: neutrophils\")","PMN_mock_60min","PMN_mock_60min_rep1"
"631","GSM466519","c(\"gender: female\", \"cell type: neutrophils\")","PMN_mock_60min","PMN_mock_60min_rep2"
"632","GSM466515","c(\"gender: female\", \"cell type: neutrophils\")","PMN_UTI89_60min","PMN_UTI89_60min_rep2"
"633","GSM466516","c(\"gender: male\", \"cell type: neutrophils\")","PMN_MG1655_60min","PMN_MG1655_60min_rep1"
"634","GSM466517","c(\"gender: female\", \"cell type: neutrophils\")","PMN_MG1655_60min","PMN_MG1655_60min_rep2"
"635","GSM549577","c(\"cell type: human neutrophils\", \"isolation: Microfluidics isolated\", \"condition: LPS stimulated\", \"subject: 0\")","Microfluidics isolated human neutrophils, LPS stimulated","LPS_1"
"636","GSM549578","c(\"cell type: human neutrophils\", \"isolation: Microfluidics isolated\", \"condition: LPS stimulated\", \"subject: 0\")","Microfluidics isolated human neutrophils, LPS stimulated","LPS_2"
"637","GSM549579","c(\"cell type: human neutrophils\", \"isolation: Microfluidics isolated\", \"condition: LPS stimulated\", \"subject: 0\")","Microfluidics isolated human neutrophils, LPS stimulated","LPS_3"
"638","GSM549580","c(\"cell type: human neutrophils\", \"isolation: Microfluidics isolated\", \"condition: LPS stimulated\", \"subject: 0\")","Microfluidics isolated human neutrophils, LPS stimulated","LPS_4"
"639","GSM549581","c(\"cell type: human neutrophils\", \"isolation: Microfluidics isolated\", \"condition: GM-CSF and IFNg stimulated\", \"subject: 0\")","Microfluidics isolated human neutrophils, GM-CSF and IFNg stimulated","GM-CSF_IFNr_1"
"640","GSM549582","c(\"cell type: human neutrophils\", \"isolation: Microfluidics isolated\", \"condition: GM-CSF and IFNg stimulated\", \"subject: 0\")","Microfluidics isolated human neutrophils, GM-CSF and IFNg stimulated","GM-CSF_IFNr_2"
"641","GSM549583","c(\"cell type: human neutrophils\", \"isolation: Microfluidics isolated\", \"condition: GM-CSF and IFNg stimulated\", \"subject: 0\")","Microfluidics isolated human neutrophils, GM-CSF and IFNg stimulated","GM-CSF_IFNr_3"
"642","GSM549584","c(\"cell type: human neutrophils\", \"isolation: Microfluidics isolated\", \"condition: GM-CSF and IFNg stimulated\", \"subject: 0\")","Microfluidics isolated human neutrophils, GM-CSF and IFNg stimulated","GM-CSF_IFNr_4"
"643","GSM310435","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Naive B cells","Naive B Cells; Naive_39"
"644","GSM310436","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Naive B cells","Naive B Cells; Naive_41"
"645","GSM310437","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Naive B cells","Naive B Cells; Naive_48"
"646","GSM310429","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Germinal Center B cells","Germinal Center B cells; GC_40"
"647","GSM310430","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Germinal Center B cells","Germinal Center B cells; GC_43"
"648","GSM310431","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Germinal Center B cells","Germinal Center B cells; GC_50"
"649","GSM310438","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Memory B cells","Memory B cells; MM_28"
"650","GSM310439","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Memory B cells","Memory B cells; MM_36"
"651","GSM310440","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Memory B cells","Memory B cells; MM_38"
"652","GSM310432","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Plasma B cells","Plasma B Cells; PC_30"
"653","GSM310433","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Plasma B cells","Plasma B Cells; PC_33"
"654","GSM310434","Acutly resected tonsils from young patients undergoing routine tonsillectomy","Plasma B cells","Plasma B Cells; PC_44"
"655","GSM381339","c(\"cell suspension: Flow sorted cells\", \"cell type: centroblast, tonsil\")","Inflamed non tumoral human tonsil#6","centroblast, tonsil#6"
"656","GSM381341","c(\"cell suspension: Flow sorted cells\", \"cell type: centroblast, tonsil\")","Inflamed non tumoral human tonsil#7","centroblast, tonsil#7"
"657","GSM381343","c(\"cell suspension: Flow sorted cells\", \"cell type: centroblast, tonsil\")","Inflamed non tumoral human tonsil#8","centroblast, tonsil#8"
"658","GSM381345","c(\"cell suspension: Flow sorted cells\", \"cell type: centroblast, tonsil\")","Inflamed non tumoral human tonsil#11","centroblast, tonsil#11"
"659","GSM381340","c(\"cell suspension: Flow sorted cells\", \"cell type: centrocyte, tonsil\")","Inflamed non tumoral human tonsil#6","centrocyte, tonsil#6"
"660","GSM381342","c(\"cell suspension: Flow sorted cells\", \"cell type: centrocyte, tonsil\")","Inflamed non tumoral human tonsil#7","centrocyte, tonsil#7"
"661","GSM381344","c(\"cell suspension: Flow sorted cells\", \"cell type: centrocyte, tonsil\")","Inflamed non tumoral human tonsil#8","centrocyte, tonsil#8"
"662","GSM381346","c(\"cell suspension: Flow sorted cells\", \"cell type: centrocyte, tonsil\")","Inflamed non tumoral human tonsil#11","centrocyte, tonsil#11"
"663","GSM304260","c(\"Genotype: Human Oocytes from reproductively healthy individuals with regular ovulatory cycles, male factor as the only cause for infertility\", \"Age: < 35 yrs.\")","Pool of 10 human oocytes","human oocyte, biological rep1"
"664","GSM304261","c(\"Genotype: Human Oocytes from reproductively healthy individuals with regular ovulatory cycles, male factor as the only cause for infertility\", \"Age: < 35 yrs.\")","Pool of 10 human oocytes","human oocyte, biological rep2"
"665","GSM304262","c(\"Genotype: Human Oocytes from reproductively healthy individuals with regular ovulatory cycles, male factor as the only cause for infertility\", \"Age: < 35 yrs.\")","Pool of 10 human oocytes","human oocyte, biological rep3"
"666","GSM158468","Fertility Status: Fertile","Normal Human Sperm","Normospermic individual: Sample N2"
"667","GSM158470","Fertility Status: Fertile","Normal Human Sperm","Normospermic individual: Sample N4"
"668","GSM1209554","cell type: B cell","B cell","B cell 1"
"669","GSM1209555","cell type: B cell","B cell","B cell 2"
"670","GSM1209556","cell type: B cell","B cell","B cell 3"
"671","GSM1209557","cell type: B cell","B cell","B cell 4"
"672","GSM1209558","cell type: Neutrophils","Neutrophil","Neutrophil 1"
"673","GSM1209559","cell type: Neutrophils","Neutrophil","Neutrophil 2"
"674","GSM1209560","cell type: Neutrophils","Neutrophil","Neutrophil 3"
"675","GSM1209561","cell type: T cells","T_cells:CD8+_Central_memory_:r1","T_cells:CD8+_Central_memory_:r1"
"676","GSM1209562","cell type: T cells","T_cells:CD8+_Central_memory_:r2","T_cells:CD8+_Central_memory_:r2"
"677","GSM1209563","cell type: T cells","T_cells:CD8+_Central_memory_:r3","T_cells:CD8+_Central_memory_:r3"
"678","GSM1209564","cell type: T cell","T_cell:CD8+:r1","T_cell:CD8+:r1"
"679","GSM1209565","cell type: T cell","T_cell:CD4+:r2","T_cell:CD4+:r2"
"680","GSM1209566","cell type: T cell","T_cell:CD8+:r3","T_cell:CD8+:r3"
"681","GSM1209567","cell type: T cell","T_cell:CD4+:r4","T_cell:CD4+:r4"
"682","GSM1209568","cell type: T cell","T_cell:CD8+:r5","T_cell:CD8+:r5"
"683","GSM1209569","cell type: T cell","T_cell:CD8+:r6","T_cell:CD8+:r6"
"684","GSM1209570","cell type: T cell","T_cell:CD8+:r7","T_cell:CD8+:r7"
"685","GSM1209571","cell type: T cell","T_cell:CD4+:r8","T_cell:CD4+:r8"
"686","GSM1209572","cell type: T cell","T_cell:CD8+:r9","T_cell:CD8+:r9"
"687","GSM1209573","cell type: T cell","T_cell:CD8+_effector_memory_RA:r1","T_cell:CD8+_effector_memory_RA:r1"
"688","GSM1209574","cell type: T cell","T_cell:CD8+_effector_memory_RA:r2","T_cell:CD8+_effector_memory_RA:r2"
"689","GSM1209575","cell type: T cell","T_cell:CD8+_effector_memory_RA:r3","T_cell:CD8+_effector_memory_RA:r3"
"690","GSM1209576","cell type: T cell","T_cell:CD8+_effector_memory_RA:r4","T_cell:CD8+_effector_memory_RA:r4"
"691","GSM1209577","cell type: T cell","T_cell:CD8+_effector_memory:r1","T_cell:CD8+_effector_memory:r1"
"692","GSM1209578","cell type: T cell","T_cell:CD8+_effector_memory:r2","T_cell:CD8+_effector_memory:r2"
"693","GSM1209579","cell type: T cell","T_cell:CD8+_effector_memory:r3","T_cell:CD8+_effector_memory:r3"
"694","GSM1209580","cell type: T cell","T_cell:CD8+_effector_memory:r4","T_cell:CD8+_effector_memory:r4"
"695","GSM1209581","cell type: T cell","T_cell:CD8+_naive:r1","T_cell:CD8+_naive:r1"
"696","GSM1209582","cell type: T cell","T_cell:CD8+_naive:r2","T_cell:CD8+_naive:r2"
"697","GSM1209583","cell type: T cell","T_cell:CD8+_naive:r3","T_cell:CD8+_naive:r3"
"698","GSM1209584","cell type: T cell","T_cell:CD8+_naive:r4","T_cell:CD8+_naive:r4"
"699","GSM1209585","cell type: Monocyte","Monocyte","Monocyte 1"
"700","GSM1209586","cell type: Monocyte","Monocyte","Monocyte 2"
"701","GSM1209587","cell type: Monocyte","Monocyte","Monocyte 3"
"702","GSM1209588","cell type: Monocyte","Monocyte","Monocyte 4"
"703","GSM1209589","cell type: Monocyte","Monocyte","Monocyte 5"
"704","GSM1209590","cell type: Monocyte","Monocyte","Monocyte 6"
"705","GSM1209591","cell type: Erythroblast","Erythroblast","Erythroblast 1"
"706","GSM1209592","cell type: Erythroblast","Erythroblast","Erythroblast 2"
"707","GSM1209593","cell type: Erythroblast","Erythroblast","Erythroblast 3"
"708","GSM1209594","cell type: Erythroblast","Erythroblast","Erythroblast 4"
"709","GSM1209595","cell type: Erythroblast","Erythroblast","Erythroblast 5"
"710","GSM1209596","cell type: Erythroblast","Erythroblast","Erythroblast 6"
"711","GSM1209597","cell type: Erythroblast","Erythroblast","Erythroblast 7"
"712","GSM1209598","cell type: Erythroblast","Erythroblast","Erythroblast 8"
"713","GSM1209599","cell type: Bone marrow & progenitors","Bone marrow & progenitors","Bone marrow & progenitors"
